AXA/2025/FY/Earnings presentation: Difference between revisions
doc_archive: publish snjra2xp9r (.md link) |
doc_archive: publish snjra2xp9r |
||
| Line 10: | Line 10: | ||
| pages = 49 |
| pages = 49 |
||
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
||
| summary_md = |
| summary_md = <!-- ARCHIVE_MD_LINK_HERE --> |
||
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages). |
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages). |
||
| wide = yes |
| wide = yes |
||
| Line 21: | Line 21: | ||
=== Full Year 2025 Earnings Presentation === |
=== Full Year 2025 Earnings Presentation === |
||
{{chunk|doc=snjra2xp9r|c=1|p=1}} |
|||
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures === |
|||
====== Presentation date ====== |
|||
* The presentation date is February 26, [[Definition:Year 2026|2026]]. |
|||
{{chunk|doc=snjra2xp9r|c=1|p=2}} |
|||
====== Forward-looking statements and non-GAAP measures ====== |
|||
=== Full Year 2025 Earnings === |
|||
* Statements in this document may be forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and non-historical information. |
|||
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could". |
|||
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking and provide one-off guidance for the last year of the Group's current strategic plan. |
|||
* These statements are based on Management's current views and intentions and are subject to change. |
|||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially. |
|||
* Each forward-looking statement is valid only at the date of this presentation. |
|||
* Refer to Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 (the "2024 Universal Registration Document") for important factors, risks, and uncertainties. |
|||
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations. |
|||
* This presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position. |
|||
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies. |
|||
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS. |
|||
* "[[Definition:Underlying earnings|Underlying earnings]]", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015. |
|||
* AXA provides a reconciliation of APMs to the most closely related line item, subtotal, or total in the financial statements in its Activity Report as of December 31, 2025 ("AXA's 2025 Activity Report"), under the heading "USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES". |
|||
* Further information on non-GAAP financial measures is available in the Glossary of AXA's 2025 Activity Report. |
|||
* AXA's Activity Report as of December 31, 2025, is available on the AXA Group website (www.axa.com). |
|||
{{chunk|doc=snjra2xp9r|c=2|p=2}} |
{{chunk|doc=snjra2xp9r|c=2|p=2}} |
||
====== |
====== Legal and cautionary statements ====== |
||
* Certain statements in the presentation are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and other non-historical information. |
|||
* AXA's consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, [[Definition:Year 2026|2026]]. |
|||
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could". |
|||
* The financial statements are subject to completion of an audit procedure by AXA's statutory auditors. |
|||
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking statements providing one-off guidance for the last year of the Group’s current strategic plan. |
|||
* These statements are based on Management’s current views and intentions and are subject to change. |
|||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA’s control, which can cause actual results to differ materially. |
|||
* Each forward-looking statement is valid only at the date of the presentation. |
|||
* For important factors, risks, and uncertainties affecting AXA’s business and/or results, refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2024 (the “2024 Universal Registration Document”). |
|||
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations. |
|||
* The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position. |
|||
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies. |
|||
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS. |
|||
* "[[Definition:Underlying earnings|Underlying earnings]]", UEPS (“underlying earnings per share”), “underlying return on equity”, “combined ratio”, and “debt gearing” are APMs as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015. |
|||
* AXA provides a reconciliation of APMs to related financial statement items and/or their calculation methodology in its Activity Report as of December 31, 2025 (“AXA’s 2025 Activity Report”), under the heading “USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES”. |
|||
* Further information on non-GAAP financial measures is available in the Glossary in AXA’s 2025 Activity Report. |
|||
* AXA’s Activity Report as of December 31, 2025, is available on the AXA Group website (www.axa.com). |
|||
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors. |
|||
{{chunk|doc=snjra2xp9r|c=3|p=3}} |
{{chunk|doc=snjra2xp9r|c=3|p=3}} |
||
====== Presentation |
====== Presentation structure and speakers ====== |
||
* [[Definition:Full year 2025|FY25]] Highlights |
* The presentation includes "[[Definition:Full year 2025|FY25]] Highlights" on page 04, presented by Thomas Buberl, Group CEO. |
||
* FY25 Business Performance |
* "FY25 Business Performance" is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
||
* FY25 Financial Performance |
* "FY25 Financial Performance" is on page 13, presented by Alban de Mailly Nesle, Group CFO. |
||
== FY25 Highlights == |
== FY25 Highlights == |
||
{{chunk|doc=snjra2xp9r|c=4|p=4}} |
{{chunk|doc=snjra2xp9r|c=4|p=4}} |
||
====== |
====== Group CEO ====== |
||
* Thomas Buberl is the Group CEO. |
* Thomas Buberl is the Group CEO. |
||
| Line 65: | Line 65: | ||
{{chunk|doc=snjra2xp9r|c=5|p=5}} |
{{chunk|doc=snjra2xp9r|c=5|p=5}} |
||
====== Financial performance |
====== Financial performance FY25 ====== |
||
* Revenues +6% vs. [[Definition:Full year 2024|FY24]] |
* Revenues +6% vs. [[Definition:Full year 2024|FY24]] |
||
* ROE 16% in [[Definition:Full year 2025|FY25]] |
|||
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24 |
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24 |
||
* |
* ROE 16% [[Definition:Full year 2025|FY25]] |
||
* Solvency II ratio 224% FY25 |
|||
* Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual [[Definition:Share buyback|share buyback]] |
|||
* Confident to deliver underlying EPS growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]] |
|||
{{chunk|doc=snjra2xp9r|c=6|p=5}} |
{{chunk|doc=snjra2xp9r|c=6|p=5}} |
||
====== Shareholder returns and future outlook ====== |
|||
* Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual [[Definition:Share buyback|share buyback]] |
|||
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]] |
|||
{{chunk|doc=snjra2xp9r|c=7|p=5}} |
|||
====== Full Year 2025 – Excellent performance ====== |
====== Full Year 2025 – Excellent performance ====== |
||
{{fn note|1=1|2=Based on the dividend proposed by |
{{fn note|1=1|2=Based on the dividend proposed by AXA's Board of Directors on February 25, 2026 and subject to approval by the Shareholders' Annual General Meeting to be held on April 30, 2026.}} |
||
{{fn note|1=2|2=Following |
{{fn note|1=2|2=Following AXA's Board of Directors' approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.}} |
||
=== Executing the plan on growth, margin and efficiency === |
=== Executing the plan on growth, margin and efficiency === |
||
{{chunk|doc=snjra2xp9r|c=7|p=6}} |
|||
====== Executing the plan on growth, margin and efficiency ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Bar chart: [[Definition:Underlying earnings|Underlying earnings]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
FY24: 8.1 |
|||
FY25: 8.4 |
|||
Change: +6% |
|||
Annotation: +9% excluding [[Definition:AXA Investment Managers|AXA IM]] |
|||
</div> |
|||
==== +6% top line growth, well balanced across ==== |
|||
{{chunk|doc=snjra2xp9r|c=8|p=6}} |
{{chunk|doc=snjra2xp9r|c=8|p=6}} |
||
====== |
====== Underlying earnings by FY24, FY25, Change ====== |
||
<div style="overflow-x:auto"> |
|||
* Top line growth +6%, balanced across lines: |
|||
{| id="t1" class="wikitable fintable" |
|||
** P&C: +5% |
|||
|- |
|||
** Life: +9% |
|||
! style="text-align:left" | |
|||
** Health: +5% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
* Record profitability with further margin expansion in P&C and L&H |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
* Improvement in efficiency |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=9|p=6}} |
|||
| style="text-align:left" | Underlying earnings |
|||
====== Business scaling and earnings ====== |
|||
| style="text-align:right" | 8.1 |
|||
| style="text-align:right" | 8.4 |
|||
* Continued investments in growth and technology |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Underlying earnings excluding AXA IM |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | +9% |
|||
|} |
|||
</div> |
|||
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) |
|||
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency |
|||
* Scaling the business: Continued investments in growth and technology |
|||
* Consistent earnings growth while enhancing reserve prudence |
* Consistent earnings growth while enhancing reserve prudence |
||
{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}} |
|||
=== Diversified franchise, well positioned in an attractive industry === |
=== Diversified franchise, well positioned in an attractive industry === |
||
| Line 116: | Line 119: | ||
==== Secular trends fueling demand across businesses ==== |
==== Secular trends fueling demand across businesses ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=9|p=7}} |
||
====== |
====== Share by segment ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t2" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Pie chart: [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|gross written premium]] split excluding [[Definition:AXA Investment Managers|AXA IM]] and holdings, by business line. |
|||
! style="text-align:left" | Segment |
|||
Life (33%) |
|||
! class="col-s" style="text-align:right" | Share |
|||
Health (17%) |
|||
|- |
|||
Retail (17%) |
|||
| style="text-align:left" | Life |
|||
Large & Specialty (17%) |
|||
| style="text-align:right" | 33% |
|||
SME & Mid-market (16%) |
|||
|- |
|||
AXA logo at center. |
|||
| style="text-align:left" | Health |
|||
| style="text-align:right" | 17% |
|||
|- |
|||
| style="text-align:left" | Large & Specialty |
|||
| style="text-align:right" | 17% |
|||
|- |
|||
| style="text-align:left" | Retail |
|||
| style="text-align:right" | 17% |
|||
|- |
|||
| style="text-align:left" | SME & Mid-market |
|||
| style="text-align:right" | 16% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=10|p=7}} |
||
====== |
====== Secular trends fueling demand ====== |
||
* Protection gaps and emerging corporate risks are driving demand |
* Protection gaps and emerging corporate risks are driving demand. |
||
* Demographics are driving demand for private retirement and healthcare. |
* Demographics are driving demand for private retirement and healthcare. |
||
==== Our right to win ==== |
==== Our right to win ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=11|p=7}} |
||
====== Competitive advantages ====== |
====== Competitive advantages ====== |
||
| Line 145: | Line 160: | ||
* Technical expertise in pricing and underwriting risks |
* Technical expertise in pricing and underwriting risks |
||
* Scale offering cost advantage |
* Scale offering cost advantage |
||
{{chunk|doc=snjra2xp9r|c=12|p=7}} |
|||
====== Our right to win ====== |
|||
{{fn note|1=1|2=Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.}} |
|||
=== Laying the foundation for the next plan === |
=== Laying the foundation for the next plan === |
||
{{chunk|doc=snjra2xp9r|c=13|p=8}} |
{{chunk|doc=snjra2xp9r|c=13|p=8}} |
||
====== |
====== Strategic priorities ====== |
||
* Clear tech and AI roadmap |
* Clear tech and AI roadmap |
||
* Driving efficiency |
* Driving efficiency |
||
* Enhancing capital allocation discipline |
* Enhancing capital allocation discipline |
||
* Building resilience |
|||
* Confidence in sustaining earnings growth |
|||
== FY25 Business Performance == |
|||
==== Confidence in sustaining earnings growth ==== |
|||
{{chunk|doc=snjra2xp9r|c=14|p= |
{{chunk|doc=snjra2xp9r|c=14|p=9}} |
||
====== |
====== Executive roles ====== |
||
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
|||
* GIE_AXA_Internal Building resilience |
|||
{{chunk|doc=snjra2xp9r|c=14|p=9|cont=1}} |
|||
* Guillaume Borie is Global Head of Finance, Strategy, Underwriting, Risk, and Technology |
|||
=== Strong delivery across our businesses === |
=== Strong delivery across our businesses === |
||
| Line 170: | Line 190: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t3" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:right" | Gross written premiums |
! style="text-align:right" | Gross written premiums |
||
! style="text-align:right" | Underlying earnings |
! style="text-align:right" | Underlying earnings |
||
|- |
|||
| style="text-align:left" | France (27% of total GWP{{fn ref|1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}) |
|||
| style="text-align:right" | +6% to €31bn |
|||
| style="text-align:right" | +7% to €2.2bn |
|||
|- |
|||
| style="text-align:left" | Europe (38% of total GWP{{fn ref|1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}) |
|||
| style="text-align:right" | +6% to €43bn |
|||
| style="text-align:right" | +9% to €3.5bn |
|||
|- |
|||
| style="text-align:left" | AXA XL (17% of total GWP{{fn ref|1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}) |
|||
| style="text-align:right" | +4% to €19bn |
|||
| style="text-align:right" | +9% to €1.9bn |
|||
|- |
|||
| style="text-align:left" | Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}) |
|||
| style="text-align:right" | +13% to €20bn |
|||
| style="text-align:right" | +6% to €1.5bn |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>France (27% of total [[Definition:Gross written premiums|GWP]]{{fn ref|1}})</td><td>+6% to €31bn</td><td>+7% to €2.2bn</td></tr> |
|||
{{fn note|1=1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}} |
|||
<tr><td>Europe (38% of total GWP{{fn ref|1}})</td><td>+6% to €43bn</td><td>+9% to €3.5bn</td></tr> |
|||
<tr><td>AXA XL (17% of total GWP{{fn ref|1}})</td><td>+4% to €19bn</td><td>+9% to €1.9bn</td></tr> |
|||
<tr><td>Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1}})</td><td>+13% to €20bn</td><td>+6% to €1.5bn</td></tr> |
|||
</table> |
|||
{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}} |
|||
=== P&C – Strong margins, confidence in sustaining growth === |
=== P&C – Strong margins, confidence in sustaining growth === |
||
{{chunk|doc=snjra2xp9r|c=16|p=11}} |
{{chunk|doc=snjra2xp9r|c=16|p=11}} |
||
====== |
====== Gross written premiums ====== |
||
* [[Definition:Gross written premiums|Gross Written Premiums]] (GWP) were EUR 58bn. |
|||
<div class="ed-chart-desc"> |
|||
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty). |
|||
[Chart/image description:] |
|||
Donut chart: [[Definition:Gross written premiums|GWP]] breakdown, €58bn total. |
|||
- Retail: share not printed |
|||
- AXA XL{{fn ref|1}} (Large & Specialty): share not printed |
|||
- SME & Mid-market: share not printed |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=17|p=11}} |
{{chunk|doc=snjra2xp9r|c=17|p=11}} |
||
====== |
====== 2025 and Beyond ====== |
||
<div style="overflow-x:auto"> |
|||
* [[Definition:Underlying earnings|Underlying earnings]] +9% to EUR 5.9bn. |
|||
{| id="t4" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! style="text-align:left" | 2025 |
|||
! style="text-align:left" | Beyond 2025 |
|||
|- |
|||
| style="text-align:left" | Retail and SME & Mid-market |
|||
| style="text-align:left" | Growing volumes while expanding margins |
|||
| style="text-align:left" | Investing to improve customer retention & expanding distribution footprint |
|||
|- |
|||
| style="text-align:left" | AXA XL (Large & Specialty) |
|||
| style="text-align:left" | Profitable growth with stable margins |
|||
| style="text-align:left" | Capitalizing on attractive growth opportunities and continued cycle management |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=18|p=11}} |
{{chunk|doc=snjra2xp9r|c=18|p=11}} |
||
====== |
====== Underlying earnings and efficiency ====== |
||
* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn |
|||
<div class="ed-chart-desc"> |
|||
* Continued progress on efficiency |
|||
[Chart/image description:] |
|||
* Higher investment income |
|||
Table/Grid: Strategic outlook for 2025 and Beyond 2025. |
|||
* Data & AI to further enhance customer experience & technical excellence |
|||
- Retail and SME & Mid-market: |
|||
- 2025: Growing volumes while expanding margins |
|||
- Beyond 2025: Investing to improve customer retention & expanding distribution footprint |
|||
- AXA XL (Large & Specialty): |
|||
- 2025: Profitable growth with stable margins |
|||
- Beyond 2025: Capitalizing on attractive growth opportunities and continued cycle management |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=19|p=11}} |
{{chunk|doc=snjra2xp9r|c=19|p=11}} |
||
====== P&C – Strong margins, confidence in sustaining growth ====== |
====== P&C – Strong margins, confidence in sustaining growth ====== |
||
{{fn note|1=1|2=Includes AXA XL Re premiums of €2.6bn.}} |
|||
<div class="ed-chart-desc"> |
|||
{{fn note|1=2|2=Change FY25 vs. FY24 at constant FX.}} |
|||
[Chart/image description:] |
|||
Flow diagram: Drivers of growth (indicated by a plus sign). |
|||
- Continued progress on efficiency |
|||
- Higher investment income |
|||
- Data & AI to further enhance customer experience & technical excellence |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=20|p=11}} |
|||
====== P&C – Strong margins, confidence in sustaining growth ====== |
|||
{{fn note|1=1|2=1. Includes AXA XL Re premiums of €2.6bn.}} |
|||
{{fn note|1=2|2=2. Change FY25 vs. FY24 at constant FX.}} |
|||
=== L&H – Good momentum, well positioned to capture growth opportunities === |
=== L&H – Good momentum, well positioned to capture growth opportunities === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=20|p=12}} |
||
====== GWP by Short-term and Long-term ====== |
|||
====== L&H – Good momentum, well positioned to capture growth opportunities ====== |
|||
<div |
<div style="overflow-x:auto"> |
||
{| id="t5" class="wikitable" |
|||
[Chart/image description:] |
|||
|- |
|||
Donut chart: [[Definition:Gross written premiums|Gross Written Premium]] (GWP) split by business line, in Euro billion. |
|||
| style="text-align:left" | Short-term |
|||
- Short-term: ~€15bn (dark blue segment) |
|||
| style="text-align:right" | Long-term |
|||
- Long-term: ~€42bn (light blue segment) |
|||
|} |
|||
- Center label: €57bn GWP |
|||
</div> |
</div> |
||
==== 2025 Beyond 2025 ==== |
|||
{{chunk|doc=snjra2xp9r|c=22|p=12}} |
|||
====== Underlying earnings ====== |
|||
{{chunk|doc=snjra2xp9r|c=21|p=12}} |
|||
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn. |
|||
====== Strategic priorities for 2025 and Beyond 2025 ====== |
|||
* Long-term business: |
|||
{{chunk|doc=snjra2xp9r|c=23|p=12}} |
|||
** 2025: Accelerating net flows in Savings at attractive margins |
|||
====== L&H – Good momentum, well positioned to capture growth opportunities ====== |
|||
** Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for customers |
|||
* Short-term business: |
|||
** 2025: Growing technical results while absorbing Mexico VAT impact |
|||
** Beyond 2025: Capitalizing on demand for health & protection while further improving margins |
|||
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn |
|||
* Focus on cost reduction |
|||
* Increasing penetration of Protection riders in Savings offerings |
|||
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health |
|||
{{chunk|doc=snjra2xp9r|c=22|p=12}} |
|||
<div class="ed-chart-desc"> |
|||
====== 2025 Beyond 2025 ====== |
|||
[Chart/image description:] |
|||
Two-column roadmap: Strategic priorities for 2025 and Beyond 2025. |
|||
Left column header: 2025 |
|||
- Long-term business: Accelerating net flows in Savings at attractive margins |
|||
- Short-term business: Growing technical results while absorbing Mexico VAT impact |
|||
Right column header: Beyond 2025 |
|||
- Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for our customers |
|||
- Short-term business: Capitalizing on demand for health & protection while further improving our margins |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=24|p=12}} |
|||
====== L&H – Good momentum, well positioned to capture growth opportunities ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Three horizontal strategy boxes below the roadmap, connected by a central plus icon. |
|||
- Left box: Focus on cost reduction |
|||
- Center box: Increasing penetration of Protection riders in Savings offerings |
|||
- Right box: Leveraging AI to reduce claims leakage & improve customer outcomes in Health |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=25|p=12}} |
|||
====== L&H – Good momentum, well positioned to capture growth opportunities ====== |
|||
{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}} |
{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}} |
||
| Line 294: | Line 283: | ||
== FY25 Financial Performance == |
== FY25 Financial Performance == |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=23|p=13}} |
||
====== Group CFO ====== |
====== Group CFO ====== |
||
| Line 301: | Line 290: | ||
=== P&C – Continued disciplined growth === |
=== P&C – Continued disciplined growth === |
||
{{chunk|doc=snjra2xp9r|c=24|p=14}} |
|||
==== GWP & Other Revenues ==== |
|||
====== Currency notation ====== |
|||
* All figures are in EUR billion. |
|||
{{chunk|doc=snjra2xp9r|c=27|p=14}} |
|||
====== GWP & Other Revenues ====== |
|||
==== GWP & Other Revenues ==== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Stacked bar chart: [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=25|p=14}} |
||
====== GWP & |
====== GWP & other revenues by lines of business ====== |
||
<div style="overflow-x:auto"> |
|||
* [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]] increased +5% to EUR 58.0bn in [[Definition:Full year 2025|FY25]] (prior: EUR 56.5bn). |
|||
{| id="t6" class="wikitable fintable" |
|||
* Commercial lines GWP & Other Revenues were EUR 35.8bn, with +4% change, comprising +2% from pricing and +2% from volume. |
|||
|- |
|||
* AXA XL Reinsurance GWP & Other Revenues were EUR 2.6bn, with +8% change, comprising +0.3% from pricing and +7% from volume. |
|||
! style="text-align:left" | |
|||
* Retail lines GWP & Other Revenues were EUR 19.7bn, with +7% change, comprising +5% from pricing and +2% from volume. |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
{{chunk|doc=snjra2xp9r|c=29|p=14}} |
|||
! class="col-s" style="text-align:right" | Change |
|||
====== GWP & Other Revenues ====== |
|||
! class="col-s" style="text-align:right" | o/w pricing{{fn ref|1}} |
|||
! class="col-s" style="text-align:right" | o/w volume{{fn ref|2}} |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Commercial lines |
|||
Table panel showing Change, o/w pricing, o/w volume columns alongside the bar chart as described above. |
|||
| rowspan="3" style="text-align:right" | 56.5 |
|||
| style="text-align:right" | 35.8 |
|||
| style="text-align:right" | +4% |
|||
| style="text-align:right" | +2% |
|||
| style="text-align:right" | +2% |
|||
|- |
|||
| style="text-align:left" | AXA XL Reinsurance |
|||
| style="text-align:right" | 2.6 |
|||
| style="text-align:right" | +8% |
|||
| style="text-align:right" | +0.3% |
|||
| style="text-align:right" | +7% |
|||
|- |
|||
| style="text-align:left" | Retail lines |
|||
| style="text-align:right" | 19.7 |
|||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | +5% |
|||
| style="text-align:right" | +2% |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 56.5 |
|||
| style="text-align:right" | 58.0 |
|||
| style="text-align:right" | +5% |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=26|p=14}} |
||
====== Commercial |
====== Commercial lines growth drivers ====== |
||
* Continued pricing momentum and volume growth in Mid-market and SME |
* Continued pricing momentum and volume growth in Mid-market and SME. |
||
* Growth in lines of business with attractive margins |
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance. |
||
* Growth supported by alternative capital |
* Growth supported by alternative capital. |
||
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]) |
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]). |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=27|p=14}} |
||
====== GWP & Other Revenues ====== |
====== GWP & Other Revenues ====== |
||
| Line 345: | Line 356: | ||
==== Combined ratio ==== |
==== Combined ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=28|p=15}} |
||
====== Combined ratio ====== |
====== Combined ratio ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t7" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Stacked bar chart: Combined ratio, [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]]. |
|||
! style="text-align:left" | |
|||
FY24 Total: 91.0% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- Undiscounted CY loss ratio (ex Nat Cat): 67.4% |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- Expense ratio: 25.0% |
|||
|- |
|||
- Nat Cat: 3.8% |
|||
| style="text-align:left" | Combined ratio (total) |
|||
- Prior year reserve development: -1.6% |
|||
| style="text-align:right" | 91.0% |
|||
- Discount: -3.6% |
|||
| style="text-align:right" | 90.6% |
|||
|- |
|||
- Undiscounted CY loss ratio (ex Nat Cat): 67.0% |
|||
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat) |
|||
- Expense ratio: 24.8% |
|||
| style="text-align:right" | 67.4% |
|||
- Nat Cat: 3.4% |
|||
| style="text-align:right" | 67.0% |
|||
- Prior year reserve development: -1.1% |
|||
|- |
|||
- Discount: -3.5% |
|||
| style="text-align:left" | Expense ratio |
|||
| style="text-align:right" | 25.0% |
|||
| style="text-align:right" | 24.8% |
|||
|- |
|||
| style="text-align:left" | Nat Cat |
|||
| style="text-align:right" | 3.8% |
|||
| style="text-align:right" | 3.4% |
|||
|- |
|||
| style="text-align:left" | Prior year reserve development |
|||
| style="text-align:right" | -1.6% |
|||
| style="text-align:right" | -1.1% |
|||
|- |
|||
| style="text-align:left" | Discount |
|||
| style="text-align:right" | -3.6% |
|||
| style="text-align:right" | -3.5% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=29|p=15}} |
||
====== |
====== Combined ratio drivers ====== |
||
* Undiscounted current year loss ratio |
* Undiscounted current year loss ratio improved, excluding Nat Cat. |
||
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing. |
|||
* Undiscounted current year loss ratio (excluding Nat Cat) improved due to stable AXA XL Insurance margins at attractive levels, reflecting disciplined cycle management. |
|||
* AXA XL Insurance margins stable at attractive levels, reflecting disciplined cycle management. |
|||
* Expense ratio improved due to efficiency measures, while continuing investment in growth initiatives and technology. |
* Expense ratio improved due to efficiency measures, while continuing investment in growth initiatives and technology. |
||
{{chunk|doc=snjra2xp9r|c=30|p=15}} |
|||
====== Nat Cat and reserve management ====== |
|||
* Nat Cat charges were below the normalized load. |
* Nat Cat charges were below the normalized load. |
||
* |
* Lower reliance on prior year reserve development. |
||
* Reserve prudence |
* Reserve prudence enhanced during a favorable year. |
||
=== P&C – Earnings growth from higher underwriting and financial result === |
=== P&C – Earnings growth from higher underwriting and financial result === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=31|p=16}} |
||
====== P&C earnings growth ====== |
====== P&C earnings growth ====== |
||
* P&C earnings |
* P&C earnings grew by EUR 0.2bn to EUR 7.6bn in 2023. |
||
* This growth was driven by a higher underwriting result and a higher financial result. |
|||
{{chunk|doc=snjra2xp9r|c=32|p=16}} |
|||
==== Underlying Earnings ==== |
|||
====== Underlying earnings waterfall by step ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t8" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | Step |
|||
! class="col-s" style="text-align:right" | Value |
|||
|- |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | 5,510 |
|||
|- |
|||
| style="text-align:left" | Volume growth |
|||
| style="text-align:right" | +292 |
|||
|- |
|||
| style="text-align:left" | Margin improvement |
|||
| style="text-align:right" | +189 |
|||
|- |
|||
| style="text-align:left" | Investment income |
|||
| style="text-align:right" | +435 |
|||
|- |
|||
| style="text-align:left" | Insurance finance expenses |
|||
| style="text-align:right" | -235 |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | -169 |
|||
|- |
|||
| style="text-align:left" | Affiliates, FX & other |
|||
| style="text-align:right" | -150 |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 5,872 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=33|p=16}} |
|||
====== P&C earnings growth ====== |
|||
* P&C earnings grew +9%. |
|||
* Growth was driven by the underwriting result. |
|||
* Growth was driven by the financial result. |
|||
{{chunk|doc=snjra2xp9r|c=34|p=16}} |
|||
====== Underwriting result drivers ====== |
|||
* The underwriting result improved due to strong volume growth. |
|||
* The underwriting result improved due to an enhanced all-year combined ratio. |
|||
* The underwriting result improved while enhancing reserve prudence. |
|||
{{chunk|doc=snjra2xp9r|c=35|p=16}} |
{{chunk|doc=snjra2xp9r|c=35|p=16}} |
||
====== |
====== Financial result drivers ====== |
||
* Investment income increased due to higher volumes. |
|||
<div class="ed-chart-desc"> |
|||
* Investment income increased due to better reinvestment yields on fixed income assets. |
|||
[Chart/image description:] |
|||
* The unwind of discount of claims reserves was higher, in line with guidance. |
|||
Waterfall chart: [[Definition:Underlying earnings|Underlying Earnings]], [[Definition:Full year 2024|FY24]] to [[Definition:Full year 2025|FY25]], in Euro million. |
|||
- FY24: 5,510 |
|||
- Volume growth: +292 |
|||
- Margin improvement: +189 |
|||
- Underwriting result{{fn ref|1}} (grouping Volume growth and Margin improvement): +481 (calculated from components) |
|||
- Investment income: +435 |
|||
- Insurance finance expenses: -235 |
|||
- Financial result (grouping Investment income and Insurance finance expenses): +200 (calculated from components) |
|||
- Tax: -169 |
|||
- Affiliates, [[Definition:Foreign exchange|FX]] & other: -150 |
|||
- FY25: 5,872 |
|||
- Total change FY24 to FY25: +9% |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=36|p=16}} |
{{chunk|doc=snjra2xp9r|c=36|p=16}} |
||
====== |
====== Forex impact ====== |
||
* There was an unfavorable forex impact, notably due to USD depreciation vs. EUR. |
|||
* Better underwriting result from strong volume growth and improved all-year combined ratio, while enhancing reserve prudence |
|||
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets |
|||
* Higher unwind of discount of claims reserves, in line with guidance |
|||
* Unfavorable forex impact notably due to USD depreciation vs. EUR |
|||
{{chunk|doc=snjra2xp9r|c=37|p=16}} |
{{chunk|doc=snjra2xp9r|c=37|p=16}} |
||
====== |
====== P&C – Earnings growth from higher underwriting and financial result ====== |
||
{{fn note|1=1|2=Underwriting result includes expenses.}} |
{{fn note|1=1|2=Change at constant FX. 1. Underwriting result includes expenses.}} |
||
=== Life & Health – Strong growth in premiums, positive net flows === |
=== Life & Health – Strong growth in premiums, positive net flows === |
||
{{chunk|doc=snjra2xp9r|c=38|p=17}} |
{{chunk|doc=snjra2xp9r|c=38|p=17}} |
||
====== |
====== Life GWP & Other Revenues ====== |
||
<div style="overflow-x:auto"> |
|||
* All financial figures are in EUR billion. |
|||
{| id="t9" class="wikitable fintable" |
|||
|- |
|||
==== Life GWP & Other Revenues ==== |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Growth |
|||
|- |
|||
| style="text-align:left" | Protection |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 17.3 |
|||
| style="text-align:right" | +11% |
|||
|- |
|||
| style="text-align:left" | Unit-Linked |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 9.3 |
|||
| style="text-align:right" | +13% |
|||
|- |
|||
| style="text-align:left" | Capital light G/A |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 9.0 |
|||
| style="text-align:right" | +7% |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 1.9 |
|||
| style="text-align:right" | -7% |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 34.5 |
|||
| style="text-align:right" | 37.5 |
|||
| style="text-align:right" | +9% |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=39|p=17}} |
{{chunk|doc=snjra2xp9r|c=39|p=17}} |
||
====== |
====== Health GWP & other revenues by individual and group ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t10" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Stacked bar chart: Life [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
! style="text-align:left" | |
|||
Total: |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- FY24: 34.5 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- FY25: 37.5 (+9% change) |
|||
! class="col-s" style="text-align:right" | Growth |
|||
|- |
|||
| style="text-align:left" | Individual |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 10.5 |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Group |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 8.5 |
|||
| style="text-align:right" | +4% |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 17.5 |
|||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | +5% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=40|p=17}} |
{{chunk|doc=snjra2xp9r|c=40|p=17}} |
||
====== |
====== Flow by segment ====== |
||
<div style="overflow-x:auto"> |
|||
* Protection [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]: EUR 17.3bn (+11%) in [[Definition:Full year 2025|FY25]] |
|||
{| id="t11" class="wikitable fintable" |
|||
* Unit-linked GWP & Other Revenues: EUR 9.3bn (+13%) in FY25 |
|||
|- |
|||
* Capital light G/A GWP & Other Revenues: EUR 9.0bn (+7%) in FY25 |
|||
! style="text-align:left" | Segment |
|||
* Traditional G/A GWP & Other Revenues: EUR 1.9bn (-7%) in FY25 |
|||
! class="col-s" style="text-align:right" | Flow (€bn) |
|||
* Employee Benefits GWP & Other Revenues: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]]) in FY25 |
|||
|- |
|||
| style="text-align:left" | Protection |
|||
==== Health GWP & Other Revenues ==== |
|||
| style="text-align:right" | +4.9 |
|||
|- |
|||
| style="text-align:left" | Health |
|||
| style="text-align:right" | +2.7 |
|||
|- |
|||
| style="text-align:left" | Unit-Linked |
|||
| style="text-align:right" | +1.5 |
|||
|- |
|||
| style="text-align:left" | Capital light G/A |
|||
| style="text-align:right" | +1.2 |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | -5.0 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=41|p=17}} |
{{chunk|doc=snjra2xp9r|c=41|p=17}} |
||
====== |
====== Employee Benefits premiums ====== |
||
* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]]) |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Stacked bar chart: Health [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
Total: |
|||
- FY24: 17.5 |
|||
- FY25: 19.0 (+5% change) |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=42|p=17}} |
{{chunk|doc=snjra2xp9r|c=42|p=17}} |
||
====== Health |
====== Life & Health – Strong growth in premiums, positive net flows ====== |
||
{{fn note|1=1|2=Change at constant scope and FX. Including both short-term and long-term Employee Benefits GWP and other revenues.}} |
|||
* Individual segment: [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]] +6% to EUR 10.5bn |
|||
* Group segment: FY25 GWP & Other Revenues +4% to EUR 8.5bn |
|||
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
|||
==== Net flows: €+5.4bn vs. €+1.5bn in FY24 ==== |
|||
{{chunk|doc=snjra2xp9r|c=43|p= |
{{chunk|doc=snjra2xp9r|c=43|p=18}} |
||
====== |
====== Currency notation ====== |
||
* All figures are in EUR billion. |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Horizontal bar chart: Net flows by segment, in Euro billion. |
|||
- Protection: +4.9 |
|||
- Health: +2.7 |
|||
- Unit-Linked: +1.5 |
|||
- Capital light G/A: +1.2 |
|||
- Traditional G/A: -5.0 |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=44|p= |
{{chunk|doc=snjra2xp9r|c=44|p=18}} |
||
====== |
====== PVEP by business mix ====== |
||
<div style="overflow-x:auto"> |
|||
{{fn note|1=1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}} |
|||
{| id="t12" class="wikitable fintable" |
|||
|- |
|||
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|||
| style="text-align:left" | Protection & Health |
|||
| rowspan="4" style="text-align:right" | 50.9 |
|||
| style="text-align:right" | 31.4 |
|||
|- |
|||
| style="text-align:left" | Unit-Linked |
|||
| style="text-align:right" | 8.5 |
|||
|- |
|||
| style="text-align:left" | Capital-light G/A |
|||
| style="text-align:right" | 7.8 |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | 1.7 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 50.9 |
|||
| style="text-align:right" | 49.4 |
|||
|- |
|||
| style="text-align:left" | Change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -2% |
|||
|- |
|||
| style="text-align:left" | Protection & Health change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -4% |
|||
|- |
|||
| style="text-align:left" | Unit-Linked change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | +18% |
|||
|- |
|||
| style="text-align:left" | Capital-light G/A change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -10% |
|||
|- |
|||
| style="text-align:left" | Traditional G/A change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -10% |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=45|p=18}} |
{{chunk|doc=snjra2xp9r|c=45|p=18}} |
||
====== |
====== NB CSM (pre-tax) ====== |
||
<div style="overflow-x:auto"> |
|||
* Life & Health net flows were EUR 1.4bn in FY23. |
|||
{| id="t13" class="wikitable fintable" |
|||
* Protection & Health net flows were EUR 3.2bn in FY23. |
|||
|- |
|||
* Savings net flows were -EUR 1.8bn in FY23. |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|||
| style="text-align:left" | NB CSM (pre-tax) |
|||
| style="text-align:right" | 2.2 |
|||
| style="text-align:right" | 2.2 |
|||
|- |
|||
| style="text-align:left" | Change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | +3% |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=46|p=18}} |
{{chunk|doc=snjra2xp9r|c=46|p=18}} |
||
====== NBV (post-tax) by FY ====== |
|||
====== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
<div |
<div style="overflow-x:auto"> |
||
{| id="t14" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: PVEP, [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
! style="text-align:left" | |
|||
Protection & Health: 50.9 (FY24), 49.4 (FY25, -2%) |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
Unit-Linked: 8.5 (FY25, +18%) |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
Capital-light G/A: 7.8 (FY25, -10%) |
|||
|- |
|||
Traditional G/A: 1.7 (FY25, -10%) |
|||
| style="text-align:left" | NBV (post-tax) |
|||
| style="text-align:right" | 2.3 |
|||
| style="text-align:right" | 2.2 |
|||
|- |
|||
| style="text-align:left" | Change |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | stable |
|||
|- |
|||
| style="text-align:left" | NBV margin |
|||
| style="text-align:right" | 4.4% |
|||
| style="text-align:right" | 4.5% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=47|p=18}} |
{{chunk|doc=snjra2xp9r|c=47|p=18}} |
||
====== |
====== PVEP, NB CSM, and NBV performance ====== |
||
* NB CSM (pre-tax) was EUR 2.2bn in [[Definition:Full year 2024|FY24]] and EUR 2.2bn (+3%) in [[Definition:Full year 2025|FY25]]. |
|||
* NBV (post-tax) was EUR 2.3bn in FY24 and EUR 2.2bn (stable) in FY25. |
|||
* NBV margin was 4.4% in FY24 and 4.5% in FY25. |
|||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. |
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. |
||
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. |
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. |
||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. |
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. |
||
{{chunk|doc=snjra2xp9r|c=48|p=18}} |
|||
====== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
{{fn note|1=1|2=Change at constant scope and FX.}} |
|||
=== Life & Health – Growth in new business driving Normalized CSM growth === |
=== Life & Health – Growth in new business driving Normalized CSM growth === |
||
{{chunk|doc=snjra2xp9r|c=49|p=19}} |
|||
====== New business CSM ====== |
|||
* New business CSM: EUR 2.2bn |
|||
==== Contractual Service Margin rollforward ==== |
==== Contractual Service Margin rollforward ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=50|p=19}} |
||
====== Contractual Service Margin rollforward ====== |
====== Contractual Service Margin rollforward (In Euro billion) ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t15" class="wikitable" |
|||
[Chart/image description:] |
|||
|- |
|||
Waterfall chart: Contractual Service Margin rollforward, [[Definition:Full year 2024|FY24]] to [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
! style="text-align:left" | FY24 |
|||
- FY24: 33.6 (o/w Life: 25.8, o/w Health: 7.7) |
|||
- New business CSM |
! style="text-align:right" | New business CSM |
||
- Underlying return on in-force |
! style="text-align:left" | Underlying return on in-force |
||
- CSM release |
! style="text-align:right" | CSM release |
||
! style="text-align:right" | Economic variance |
|||
- Normalized CSM growth: +2% (grouping New business CSM, Underlying return on in-force, and CSM release) |
|||
! style="text-align:right" | Operating variance |
|||
- Economic variance: +0.6 |
|||
! style="text-align:right" | Affiliates, FX & other |
|||
- Operating variance: -0.3 |
|||
! style="text-align:right" | FY25 |
|||
- Affiliates, [[Definition:Foreign exchange|FX]] & other: -1.4 |
|||
|} |
|||
- FY25: 33.0 (o/w Life: 25.4, o/w Health: 7.6) |
|||
</div> |
</div> |
||
<tr><td>33.6</td><td>+2.2</td><td>+1.3</td><td>-3.0</td><td>+0.6</td><td>-0.3</td><td>-1.4</td><td>33.0</td></tr> |
|||
<tr><td>o/w Life: 25.8</td><td></td><td></td><td></td><td></td><td></td><td></td><td>25.4</td></tr> |
|||
<tr><td>o/w Health: 7.7</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7.6</td></tr> |
|||
</table> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=51|p=19}} |
||
====== Normalized CSM growth and drivers ====== |
|||
* Normalized CSM growth: +2% |
|||
* Normalized CSM up +2%, with CSM release growth reflecting better margins |
|||
* New business CSM growth impacted by higher rates |
|||
* Economic variance reflects government spreads tightening and positive equity market returns |
|||
* Operating variance driven by better margins and net flows, more than offset by a reduction in the duration of Group Life business in Switzerland |
|||
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation |
|||
{{chunk|doc=snjra2xp9r|c=52|p=19}} |
|||
====== Contractual Service Margin rollforward ====== |
====== Contractual Service Margin rollforward ====== |
||
{{fn note|1=1|2=Change at constant scope and FX.}} |
|||
* Normalized CSM up +2%. |
|||
* CSM release growth reflects better margins. |
|||
* New business CSM growth impacted by higher rates. |
|||
* Economic variance reflects government spreads tightening and positive equity market returns. |
|||
* Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland. |
|||
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation. |
|||
=== Life & Health – Strong momentum in both short-term and long-term business === |
=== Life & Health – Strong momentum in both short-term and long-term business === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=53|p=20}} |
||
====== |
====== Life & Health business overview ====== |
||
* All |
* All figures are in EUR million. |
||
==== Underlying Earnings ==== |
==== Underlying Earnings ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=54|p=20}} |
||
====== Underlying Earnings (In Euro million) ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t16" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! style="text-align:left" | Short-term technical margin |
|||
! style="text-align:left" | Long-term result incl. CSM release |
|||
! class="col-s" style="text-align:right" | Financial result |
|||
! class="col-s" style="text-align:right" | Tax, FX and others |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|||
| style="text-align:left" | Short-term technical margin |
|||
| style="text-align:right" | 415 |
|||
| style="text-align:left" | +60 |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 479 |
|||
|- |
|||
| style="text-align:left" | Long-term result incl. CSM release |
|||
| style="text-align:right" | 2,680 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | +156 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 2,804 |
|||
|- |
|||
| style="text-align:left" | Financial result |
|||
| style="text-align:right" | 975 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | -11 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 946 |
|||
|- |
|||
| style="text-align:left" | Tax & others |
|||
| style="text-align:right" | -748 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | -27 |
|||
| style="text-align:right" | -728 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 3,323 |
|||
| style="text-align:left" | |
|||
| style="text-align:left" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 3,501 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=55|p=20}} |
|||
====== Underlying Earnings ====== |
====== Underlying Earnings ====== |
||
* [[Definition:Underlying earnings|Underlying Earnings]]: +7% |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
{{chunk|doc=snjra2xp9r|c=56|p=20}} |
|||
Bar chart: [[Definition:Underlying earnings|Underlying earnings]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro million. |
|||
====== in billions ====== |
|||
FY24 total: 3,323 |
|||
- Short-term technical margin: 415 |
|||
<div style="overflow-x:auto"> |
|||
- Long-term result incl. CSM release: 2,680 |
|||
{| id="t17" class="wikitable fintable" |
|||
- Financial result: 975 |
|||
|- |
|||
- Tax & others: -748 |
|||
! style="text-align:left" | |
|||
Change drivers: |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- Short-term technical margin: +60 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- Long-term result incl. CSM release: +156 |
|||
! class="col-m" style="text-align:right" | Change at constant FX |
|||
- Financial result: -11 |
|||
|- |
|||
- Tax, [[Definition:Foreign exchange|FX]] and others: -27 |
|||
| style="text-align:left" | o/w Life |
|||
FY25 total: 3,501 |
|||
| style="text-align:right" | 2.6 |
|||
- Short-term technical margin: 479 |
|||
| style="text-align:right" | 2.7 |
|||
- Long-term result incl. CSM release: 2,804 |
|||
| style="text-align:right" | +4% vs. FY24 |
|||
- Financial result: 946 |
|||
|- |
|||
- Tax & others: -728 |
|||
| style="text-align:left" | o/w Health |
|||
Overall change: +7% |
|||
| style="text-align:right" | 0.7 |
|||
o/w Life: 2.6 → 2.7 (+4% vs. FY24) |
|||
| style="text-align:right" | 0.8 |
|||
o/w Health: 0.7 → 0.8 (+17% vs. FY24) |
|||
| style="text-align:right" | +17% vs. FY24 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=57|p=20}} |
||
====== |
====== Technical Margin and Long-Term Results ====== |
||
* Short-term technical margin was strong, reflecting underwriting and claims initiatives. |
* Short-term technical margin was strong, reflecting underwriting and claims initiatives. |
||
* |
* Underwriting and claims initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn). |
||
* Long-term results were higher due to an increase in CSM release (+8%). |
|||
* The increase in CSM release reflects growth in the reserve base, including from favorable equity market performance, and better margins. |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=58|p=20}} |
||
====== |
====== Underlying Earnings ====== |
||
{{fn note|1=1|2=Change at constant FX.}} |
|||
* Long-term results were higher due to an +8% increase in CSM release. |
|||
* This increase reflects growth in the reserve base, including from favorable equity market performance, and better margins. |
|||
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=59|p=21}} |
||
====== Net income by business |
====== Net income by business line ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t18" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 653: | Line 908: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=60|p=21}} |
||
====== |
====== Underlying earnings and net income drivers ====== |
||
* |
* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses. |
||
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]]. |
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]]. |
||
* Net |
* Net income was higher, mainly reflecting higher underlying earnings and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]]. |
||
* |
* Lower financial flows reflected an unfavorable forex impact. |
||
==== Underlying earnings per share ==== |
==== Underlying earnings per share ==== |
||
{{chunk|doc=snjra2xp9r|c=61|p=21}} |
|||
==== Underlying earnings per share In Euro ==== |
|||
====== Underlying earnings per share ====== |
|||
* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in Euro. |
|||
{{chunk|doc=snjra2xp9r|c=56|p=21}} |
|||
====== Underlying earnings per share in Euro ====== |
|||
{{chunk|doc=snjra2xp9r|c=62|p=21}} |
|||
* [[Definition:Underlying earnings per share|Underlying earnings per share]] in Euro |
|||
====== Underlying earnings per share (In Euro) ====== |
|||
<div style="overflow-x:auto"> |
|||
{{chunk|doc=snjra2xp9r|c=57|p=21}} |
|||
{| id="t19" class="wikitable fintable" |
|||
====== Underlying earnings per share In Euro ====== |
|||
|- |
|||
! style="text-align:left" | FY24 |
|||
<div class="ed-chart-desc"> |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | Change |
|||
Bar chart: [[Definition:Underlying earnings per share|Underlying earnings per share]], [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro. |
|||
|- |
|||
FY24: 3.59 |
|||
| style="text-align:left" | 3.59 |
|||
FY25: 3.86 |
|||
| style="text-align:right" | 3.86 |
|||
Overall change: +8% |
|||
| style="text-align:right" | +8% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=63|p=21}} |
||
====== Underlying |
====== Underlying EPS growth drivers ====== |
||
* [[Definition:Underlying earnings per share|Underlying EPS]] growth: +6% from earnings growth |
|||
* Earnings growth contributed +6%. |
|||
* [[Definition:Capital management| |
* Underlying EPS growth: +3% from [[Definition:Capital management|capital management]] |
||
* Underlying EPS growth: -2% from forex |
|||
* Forex impact was -2%. |
|||
* |
* Underlying EPS growth: -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to [[Definition:AXA Investment Managers|AXA IM]] sale, related to the timing of anti-dilutive [[Definition:Share buyback|share buyback]] |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=64|p=21}} |
||
====== |
====== Underlying earnings per share ====== |
||
{{fn note|1=1|2=Change at constant FX for underlying earnings and net income. Change on reported basis for underlying earnings per share.}} |
|||
{{chunk|doc=snjra2xp9r|c=59|p=22|cont=1}} |
|||
* All figures are in EUR billion. |
|||
=== Shareholders' Equity === |
|||
{{chunk|doc=snjra2xp9r|c=60|p=22}} |
|||
====== Underlying earnings per share In Euro ====== |
|||
==== Shareholders' equity ==== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
{{chunk|doc=snjra2xp9r|c=65|p=22}} |
|||
Stacked bar chart: Shareholders' equity{{fn ref|1}}, [[Definition:Full year 2024|FY24]], HY25, and [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
====== Shareholders' equity<sup>1</sup> ====== |
|||
- FY24: |
|||
- SHE (excl. OCI): 58.0 |
|||
<div style="overflow-x:auto"> |
|||
- Net OCI: -8.1 |
|||
{| id="t20" class="wikitable fintable" |
|||
- Total Shareholders' equity: 49.9 |
|||
|- |
|||
- SHE (excl. OCI & undated subordinated debt): 53.2 |
|||
! style="text-align:left" | |
|||
- Debt gearing: 20.6% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- Underlying ROE: 15.2% |
|||
! class="col-s" style="text-align:right" | HY25 |
|||
- HY25: |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- SHE (excl. OCI): 52.7 |
|||
|- |
|||
- Net OCI: -7.2 |
|||
| style="text-align:left" | Total |
|||
- Total Shareholders' equity: 45.5 |
|||
| style="text-align:right" | 49.9 |
|||
- SHE (excl. OCI & undated subordinated debt): 47.0 |
|||
| style="text-align:right" | 45.5 |
|||
- Debt gearing: 23.4% |
|||
| style="text-align:right" | 47.2 |
|||
- Underlying ROE: 17.5% |
|||
|- |
|||
- FY25: |
|||
- SHE (excl. OCI) |
| style="text-align:left" | SHE (excl. OCI) |
||
| style="text-align:right" | 58.0 |
|||
- Net OCI: -6.8 |
|||
| style="text-align:right" | 52.7 |
|||
- Total Shareholders' equity: 47.2 |
|||
| style="text-align:right" | 54.0 |
|||
- SHE (excl. OCI & undated subordinated debt): 49.4 |
|||
|- |
|||
- Debt gearing: 22.3% |
|||
| style="text-align:left" | Net OCI |
|||
- Underlying ROE: 16.0% |
|||
| style="text-align:right" | -8.1 |
|||
| style="text-align:right" | -7.2 |
|||
| style="text-align:right" | -6.8 |
|||
|- |
|||
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt) |
|||
| style="text-align:right" | 53.2 |
|||
| style="text-align:right" | 47.0 |
|||
| style="text-align:right" | 49.4 |
|||
|- |
|||
| style="text-align:left" | Debt gearing |
|||
| style="text-align:right" | 20.6% |
|||
| style="text-align:right" | 23.4% |
|||
| style="text-align:right" | 22.3% |
|||
|- |
|||
| style="text-align:left" | Underlying ROE |
|||
| style="text-align:right" | 15.2% |
|||
| style="text-align:right" | 17.5% |
|||
| style="text-align:right" | 16.0% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=66|p=22}} |
||
====== Shareholders' equity ====== |
====== Shareholders' equity ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t21" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | FY24 to FY25 |
! class="col-s" style="text-align:right" | FY24 to FY25 |
||
! class="col-s" style="text-align:right" | HY25 to FY25 |
! class="col-s" style="text-align:right" | HY25 to FY25 |
||
| Line 775: | Line 1,050: | ||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=1. Shareholders' equity Group share.}} |
|||
{{fn note|1=1|2=Shareholders' equity Group share. Full Year 2025 Earnings}} |
|||
=== Higher organic cash remittance and robust cash position at Holding === |
=== Higher organic cash remittance and robust cash position at Holding === |
||
{{chunk|doc=snjra2xp9r|c=67|p=23}} |
|||
====== Cash remittance and position ====== |
|||
* In EUR billion |
|||
==== Net Cash Remittance ==== |
==== Net Cash Remittance ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=68|p=23}} |
||
====== Net Cash Remittance ====== |
====== Net Cash Remittance ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t22" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: Net Cash Remittance, [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
! style="text-align:left" | |
|||
- FY24: 7.7 total (consisting of 7.1 base and 0.6 "Proceeds related to in-force treaties{{fn ref|2}}") |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- FY25: 7.5 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- Remittance ratio{{fn ref|1}}: FY24: 82%, FY25: 82% |
|||
|- |
|||
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}} |
|||
| style="text-align:right" | 0.6 |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Ordinary cash remittance |
|||
| style="text-align:right" | 7.1 |
|||
| style="text-align:right" | 7.5 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 7.7 |
|||
| style="text-align:right" | 7.5 |
|||
|- |
|||
| style="text-align:left" | Remittance ratio{{fn ref|1}} |
|||
| style="text-align:right" | 82% |
|||
| style="text-align:right" | 82% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=69|p=23}} |
||
====== Net Cash Remittance ====== |
====== Net Cash Remittance ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t23" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | FY24 Cash position |
|||
! class="col-s" style="text-align:right" | 4.0 |
|||
|- |
|- |
||
| style="text-align:left" | Net cash remittance from subsidiaries |
| style="text-align:left" | Net cash remittance from subsidiaries |
||
| Line 822: | Line 1,120: | ||
| style="text-align:right" | +3.1 |
| style="text-align:right" | +3.1 |
||
|- |
|- |
||
! style="text-align:left" | FY25 Cash position |
|||
! class="col-s" style="text-align:right" | 5.6 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2= |
{{fn note|1=1|2=Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.}} |
||
{{fn note|1=2|2= |
{{fn note|1=2|2=€0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.}} |
||
=== Solvency II at 224% === |
=== Solvency II at 224% === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=70|p=24}} |
||
====== |
====== Foreseeable dividends and share buyback provision ====== |
||
* Foreseeable [[Definition:Dividend|dividends]]: EUR -4.8bn |
|||
* Solvency II ratio at 224% |
|||
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=71|p=24}} |
||
====== |
====== Eligible Own Funds (EOF) ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t24" class="wikitable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: Eligible Own Funds (EOF) and Solvency Capital Requirement (SCR) for [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]], in Euro billion. |
|||
! style="text-align:left" | FY24 |
|||
EOF FY24: 55.9 |
|||
! style="text-align:left" | Regulatory & model changes |
|||
EOF FY25: 56.4 |
|||
! style="text-align:left" | Normalized capital generation |
|||
SCR FY24: 25.9 |
|||
! style="text-align:right" | Operating variance |
|||
SCR FY25: 25.2 |
|||
! style="text-align:right" | Economic variance & FX |
|||
Drivers of EOF change from FY24 to FY25: +0.2 (Regulatory & model changes), +8.8 (Normalized capital generation), -0.4 (Operating variance), -2.1 (Economic variance & [[Definition:Foreign exchange|FX]]), -6.0 ([[Definition:Dividend|Dividend]] & annual [[Definition:Share buyback|share buyback]]), -0.1 (Management actions, debt & other) |
|||
! style="text-align:left" | Dividend & annual share buyback |
|||
Drivers of SCR change from FY24 to FY25: 0.0 (Regulatory & model changes), +0.6 (Normalized capital generation), 0.0 (Operating variance), -1.2 (Economic variance & FX), 0.0 (Dividend & annual share buyback), -0.2 (Management actions, debt & other) |
|||
! style="text-align:left" | Management actions, debt & other |
|||
Annotation: Foreseeable dividends: €4.8bn. Provision for annual share buyback for [[Definition:Year 2026|2026]]: €1.25bn. |
|||
! style="text-align:right" | FY25 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=72|p=24}} |
||
====== Solvency II ratio movements ====== |
|||
* Solvency II ratio: 55.9 (reported) |
|||
* Solvency II ratio movements: +0.2 from operating return; +8.8 from market impacts; -0.4 from [[Definition:Capital management|capital management]]; -2.1 from regulatory changes; -6.0 from other impacts; -0.1 from [[Definition:Foreign exchange|FX]] |
|||
* Solvency II ratio at period end: 56.4 (reported) |
|||
{{chunk|doc=snjra2xp9r|c=73|p=24}} |
|||
====== Solvency II ratio ====== |
====== Solvency II ratio ====== |
||
<div style="overflow-x:auto"> |
|||
* Solvency II ratio was 216% in [[Definition:Full year 2024|FY24]] and 224% in [[Definition:Full year 2025|FY25]]. |
|||
{| id="t25" class="wikitable" |
|||
* Drivers of Solvency II ratio change from FY24 to FY25: |
|||
|- |
|||
** Regulatory & model changes: +0pt |
|||
! style="text-align:left" | FY24 |
|||
** Normalized capital generation: +28pts |
|||
! style="text-align:left" | Regulatory & model changes |
|||
** Operating variance: -1pt |
|||
! style="text-align:left" | Normalized capital generation |
|||
** Economic variance & [[Definition:Foreign exchange|FX]]: +4pts |
|||
! style="text-align:right" | Operating variance |
|||
** [[Definition:Dividend|Dividend]] & annual [[Definition:Share buyback|share buyback]]: -24pts |
|||
! style="text-align:right" | Economic variance & FX |
|||
** Management actions, debt & other: +2pts |
|||
! style="text-align:left" | Dividend & annual share buyback |
|||
! style="text-align:left" | Management actions, debt & other |
|||
! style="text-align:right" | FY25 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=74|p=24}} |
||
====== Solvency II |
====== Solvency II ratio evolution ====== |
||
* Solvency II ratio was 216%. |
|||
<div class="ed-chart-desc"> |
|||
* The ratio increased by +28pts due to operating return. |
|||
[Chart/image description:] |
|||
* The ratio decreased by -1pt due to market impacts. |
|||
#### Key sensitivities |
|||
* The ratio increased by +4pts due to [[Definition:Capital management|capital management]]. |
|||
Bar chart: Key sensitivities to Solvency II ratio as of December 31, 2025. |
|||
* The ratio decreased by -24pts due to regulatory changes. |
|||
Base ratio: 224% |
|||
* The ratio increased by +2pts due to other effects. |
|||
Interest rate +50bps: +2 pts |
|||
* The final Solvency II ratio was 224%. |
|||
Interest rate -50bps: -1 pt |
|||
Corporate spreads +50bps: -1 pt |
|||
{{chunk|doc=snjra2xp9r|c=75|p=24}} |
|||
Euro Sovereign spreads +50bps{{fn ref|1}}: -7 pts |
|||
====== Solvency Capital Requirement (SCR) ====== |
|||
Credit migration{{fn ref|2}}: -4 pts |
|||
Listed Equity (excl. PE & Infra) +25%: -1 pt |
|||
<div style="overflow-x:auto"> |
|||
Listed Equity (excl. PE & Infra) -25%: +2 pts |
|||
{| id="t26" class="wikitable" |
|||
PE & Infra +25%: +14 pts |
|||
|- |
|||
PE & Infra -25%: -19 pts |
|||
! style="text-align:left" | FY24 |
|||
Inflation swap curve +50bps: -5 pts |
|||
! style="text-align:left" | Regulatory & model changes |
|||
! style="text-align:left" | Normalized capital generation |
|||
! style="text-align:right" | Operating variance |
|||
! style="text-align:right" | Economic variance & FX |
|||
! style="text-align:left" | Dividend & annual share buyback |
|||
! style="text-align:left" | Management actions, debt & other |
|||
! style="text-align:right" | FY25 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=76|p=24}} |
||
====== Solvency II |
====== Solvency II ratio bridge ====== |
||
* Solvency II ratio bridge: 25.9 (start); 0.0 (operating capital generation); +0.6 (market impacts); 0.0 (non-operating items); -1.2 ( |
|||
==== Key sensitivities ==== |
|||
{{chunk|doc=snjra2xp9r|c=77|p=24}} |
|||
====== Impact by scenario ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t27" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | Scenario |
|||
! class="col-s" style="text-align:right" | Impact |
|||
|- |
|||
| style="text-align:left" | Ratio as of December 31, 2025 |
|||
| style="text-align:right" | 224% |
|||
|- |
|||
| style="text-align:left" | Interest rate +50bps |
|||
| style="text-align:right" | +2 pts |
|||
|- |
|||
| style="text-align:left" | Interest rate -50bps |
|||
| style="text-align:right" | -1 pt |
|||
|- |
|||
| style="text-align:left" | Corporate spreads +50bps |
|||
| style="text-align:right" | -1 pt |
|||
|- |
|||
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}} |
|||
| style="text-align:right" | -1 pt |
|||
|- |
|||
| style="text-align:left" | Credit migration{{fn ref|2}} |
|||
| style="text-align:right" | +2 pts |
|||
|- |
|||
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25% |
|||
| style="text-align:right" | -7 pts |
|||
|- |
|||
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25% |
|||
| style="text-align:right" | -4 pts |
|||
|- |
|||
| style="text-align:left" | PE & Infra +25% |
|||
| style="text-align:right" | +14 pts |
|||
|- |
|||
| style="text-align:left" | PE & Infra -25% |
|||
| style="text-align:right" | -19 pts |
|||
|- |
|||
| style="text-align:left" | Inflation swap curve +50bps |
|||
| style="text-align:right" | -5 pts |
|||
|} |
|||
</div> |
|||
{{fn note|1=1|2=Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}} |
{{fn note|1=1|2=Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}} |
||
| Line 892: | Line 1,261: | ||
=== Solvency II – impact of the end of grandfathering period and Solvency II revision === |
=== Solvency II – impact of the end of grandfathering period and Solvency II revision === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=78|p=25}} |
||
====== |
====== Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t28" class="wikitable" |
||
|- |
|- |
||
| style="text-align:left" | Ratio as of 31/12/2025 |
| style="text-align:left" | Ratio as of 31/12/2025 |
||
| Line 904: | Line 1,273: | ||
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
||
| style="text-align:right" | -10pts to 215% |
| style="text-align:right" | -10pts to 215% |
||
| style="text-align:left" | |
| style="text-align:left" | Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
||
| style="text-align:right" | +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
| style="text-align:right" | +17pts{{fn ref|1}} |
|||
| style="text-align:left" | |
| style="text-align:left" | |
||
|} |
|} |
||
</div> |
</div> |
||
No change expected in organic capital generation<br/> |
|||
Additional capital flexibility |
|||
</td> |
|||
</tr> |
|||
</table> |
|||
{{fn note|1=1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
== Conclusion == |
|||
{{fn note|1=1|2=1. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
=== Thomas Buberl, Group CEO Conclusion === |
|||
==== Conclusion ==== |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=79|p=26}} |
||
====== |
====== Group CEO ====== |
||
* Thomas Buberl is the Group CEO. |
* Thomas Buberl is the Group CEO. |
||
| Line 925: | Line 1,296: | ||
=== Conclusion === |
=== Conclusion === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=80|p=27}} |
||
====== Business performance and outlook ====== |
====== Business performance and outlook ====== |
||
* |
* Record results were achieved at the top end of the [[Definition:Target range|target range]] while enhancing reserve prudence. |
||
* All businesses are in excellent shape, delivering strong growth and profitability. |
* All businesses are in excellent shape, delivering strong growth and profitability. |
||
* The diversified franchise is well-positioned to capture future growth opportunities. |
* The diversified franchise is well-positioned to capture future growth opportunities. |
||
* |
* Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth. |
||
== Q&A == |
|||
=== February 26, 2026 Q&A Full Year 2025 Earnings === |
|||
{{chunk|doc=snjra2xp9r|c=81|p=28}} |
|||
==== Q&A Full Year 2025 Earnings ==== |
|||
====== Date ====== |
|||
* February 26, [[Definition:Year 2026|2026]] |
|||
=== AXA Investor Relations – Keep in touch === |
=== AXA Investor Relations – Keep in touch === |
||
==== Meet our management ==== |
|||
{{chunk|doc=snjra2xp9r|c=72|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
{{chunk|doc=snjra2xp9r|c=82|p=29}} |
|||
<div class="ed-chart-desc"> |
|||
====== Investor relations calendar ====== |
|||
[Chart/image description:] |
|||
Icon of a person/headset representing investor relations management. |
|||
</div> |
|||
* March: Roadshows in Europe and US |
|||
{{chunk|doc=snjra2xp9r|c=73|p=29}} |
|||
* May 5: 1Q25 Activity Indicators in Paris |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
* June 2: BNP Paribas Exane CEO Conference in Paris |
|||
* June 2-4: Goldman Sachs European Financials Conference in Zurich |
|||
* July 31: HY26 [[Definition:Earnings release|Earnings Release]] in Paris |
|||
* September 21: AXA Investor Day in London |
|||
==== Contact us ==== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t6" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | March |
|||
! style="text-align:left" | Roadshows |
|||
! style="text-align:right" | Europe and US |
|||
|- |
|||
| style="text-align:left" | May 5 |
|||
| style="text-align:left" | 1Q25 Activity Indicators |
|||
| style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2 |
|||
| style="text-align:left" | BNP Paribas Exane CEO Conference |
|||
| style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2-4 |
|||
| style="text-align:left" | Goldman Sachs European Financials Conference |
|||
| style="text-align:right" | Zurich |
|||
|- |
|||
| style="text-align:left" | July 31 |
|||
| style="text-align:left" | HY26 Earnings Release |
|||
| style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | September 21 |
|||
| style="text-align:left" | AXA Investor Day |
|||
| style="text-align:right" | London |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=83|p=29}} |
||
====== Investor Relations |
====== Investor Relations contact ====== |
||
* Investor Relations contact |
* Investor Relations contact: +33 1 40 75 48 42 |
||
* Investor Relations email: investor.relations@axa.com |
* Investor Relations email: investor.relations@axa.com |
||
==== Follow us ==== |
|||
{{chunk|doc=snjra2xp9r|c=75|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
{{chunk|doc=snjra2xp9r|c=84|p=29}} |
|||
<div class="ed-chart-desc"> |
|||
====== AXA website ====== |
|||
[Chart/image description:] |
|||
Share/follow icon. |
|||
</div> |
|||
* AXA website: www.axa.com |
|||
{{chunk|doc=snjra2xp9r|c=76|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
== Appendices == |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
YouTube icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=85|p=31}} |
||
====== |
====== Appendices overview ====== |
||
* The document includes appendices on: Debt and Invested Assets; Additional P&C disclosures; Additional IFRS17 disclosures. |
|||
* For investor relations inquiries, contact f. |
|||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
|||
{{chunk|doc=snjra2xp9r|c=78|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
{{chunk|doc=snjra2xp9r|c=86|p=32}} |
|||
<div class="ed-chart-desc"> |
|||
====== Gross financial debt and maturity breakdown ====== |
|||
[Chart/image description:] |
|||
Facebook icon. |
|||
</div> |
|||
* All figures are in EUR billion. |
|||
{{chunk|doc=snjra2xp9r|c=79|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
==== Gross financial debt ==== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Instagram icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=87|p=32}} |
||
====== |
====== Debt gearing ====== |
||
* Debt gearing: 20.6% (prior: 22.3%) |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Twitter/X icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=88|p=32}} |
||
====== |
====== Gross financial debt (In Euro billion) ====== |
||
<div style="overflow-x:auto"> |
|||
* For investor relations inquiries, contact the AXA Investor Relations team. |
|||
{| id="t29" class="wikitable fintable" |
|||
* Contact details: `axa.investor.relations@axa.com`. |
|||
|- |
|||
* Contact details: `+33 1 40 75 46 85`. |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Jan 1st 2026 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:right" | 19.2 |
|||
| style="text-align:right" | 20.3 |
|||
| style="text-align:right" | 20.3 |
|||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | 4.8 |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 3.2 |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 12.2 |
|||
| style="text-align:right" | 11.3 |
|||
|- |
|||
| style="text-align:left" | Senior debt |
|||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 5.8 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=89|p=32}} |
||
====== |
====== Gross financial debt details ====== |
||
* End of the grandfathering period |
|||
<div class="ed-chart-desc"> |
|||
* EUR 0.4bn redeemed in Jan [[Definition:Year 2026|2026]] |
|||
[Chart/image description:] |
|||
LinkedIn icon. |
|||
</div> |
|||
==== Contractual maturity breakdown ==== |
|||
{{chunk|doc=snjra2xp9r|c=83|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
{{chunk|doc=snjra2xp9r|c=90|p=32}} |
|||
<div class="ed-chart-desc"> |
|||
====== Contractual maturity breakdown (In Euro billion) ====== |
|||
[Chart/image description:] |
|||
Sustainability/leaf icon. |
|||
<div style="overflow-x:auto"> |
|||
{| id="t30" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
! class="col-s" style="text-align:right" | 2026 |
|||
! class="col-s" style="text-align:right" | 2027 |
|||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|||
| style="text-align:left" | Senior debt |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=91|p=32}} |
||
====== |
====== Contractual maturity breakdown ====== |
||
* Grandfathered debt is included in the contractual maturity breakdown. |
|||
* For investor relations, contact O. |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=92|p=32}} |
||
====== Tier 1 & Tier 2 by 2025, 2026, 2027, 2028, 2029, 2030, 2031-2039, ≥2040, Undated ====== |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
<div |
<div style="overflow-x:auto"> |
||
{| id="t31" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Additional social/web icon. |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
! class="col-s" style="text-align:right" | 2026 |
|||
! class="col-s" style="text-align:right" | 2027 |
|||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 1.4 |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | - |
|||
|} |
|||
</div> |
</div> |
||
==== Economic maturity breakdown ==== |
|||
{{chunk|doc=snjra2xp9r|c=86|p=29}} |
|||
====== AXA Investor Relations – Keep in touch ====== |
|||
{{chunk|doc=snjra2xp9r|c=93|p=32}} |
|||
<div class="ed-chart-desc"> |
|||
====== Economic maturity breakdown by senior debt, Tier 2, Tier 1 ====== |
|||
[Chart/image description:] |
|||
AXA logo. |
|||
</div> |
|||
== Appendices == |
|||
{{chunk|doc=snjra2xp9r|c=87|p=31}} |
|||
====== Additional P&C disclosures ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t32" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
! class="col-s" style="text-align:right" | 2026 |
|||
! class="col-s" style="text-align:right" | 2027 |
|||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Senior debt |
||
| style="text-align: |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Tier 2 |
||
| style="text-align: |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | 0.1 |
||
| style="text-align:right" | 2.4 |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 2.0 |
|||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Tier 1 |
||
| style="text-align: |
| style="text-align:right" | |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 0.9 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | 4.0 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=94|p=32}} |
|||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
|||
====== Grandfathered debt ====== |
|||
* o/w Grandfathered debt |
|||
{{chunk|doc=snjra2xp9r|c=88|p=32}} |
|||
====== Gross financial debt and maturity breakdown as of December 31st, 2025 ====== |
|||
{{chunk|doc=snjra2xp9r|c=95|p=32}} |
|||
<div class="ed-chart-desc"> |
|||
====== Tier 1 & Tier 2 by economic maturity ====== |
|||
[Chart/image description:] |
|||
Stacked bar chart: Gross financial debt{{fn ref|1,2}}, [[Definition:Full year 2024|FY24]] vs [[Definition:Full year 2025|FY25]] vs Jan 1st [[Definition:Year 2026|2026]] (End of the grandfathering period). |
|||
Legend: Tier 1, Tier 2, Senior debt. |
|||
- FY24: Total 19.2 (Debt gearing: 20.6%) |
|||
- Tier 1: 4.8 |
|||
- Tier 2: 10.8 |
|||
- Senior debt: 3.5 |
|||
- FY25: Total 20.3 (Debt gearing: 22.3%) |
|||
- Tier 1: 4.6 |
|||
- Tier 2: 12.2 |
|||
- Senior debt: 3.5 |
|||
- Jan 1st 2026 (End of the grandfathering period): Total 20.3 |
|||
- Tier 1: 3.2 |
|||
- Tier 2: 11.3 |
|||
- Senior debt: 5.8 (with callout: "o/w €0.4bn redeemed in Jan 2026") |
|||
</div> |
|||
<div style="overflow-x:auto"> |
|||
{{chunk|doc=snjra2xp9r|c=89|p=32}} |
|||
{| id="t33" class="wikitable fintable" |
|||
====== Gross financial debt and maturity breakdown as of December 31st, 2025 ====== |
|||
|- |
|||
! style="text-align:left" | |
|||
<div class="ed-chart-desc"> |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | 2026 |
|||
Two stacked bar charts showing maturity breakdowns. |
|||
! class="col-s" style="text-align:right" | 2027 |
|||
Legend: Tier 1, Tier 2, Senior debt. |
|||
! class="col-s" style="text-align:right" | 2028 |
|||
! class="col-s" style="text-align:right" | 2029 |
|||
! class="col-s" style="text-align:right" | 2030 |
|||
! class="col-s" style="text-align:right" | 2031-2039 |
|||
! class="col-s" style="text-align:right" | ≥2040 |
|||
! class="col-s" style="text-align:right" | Undated |
|||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.8 |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | - |
|||
| style="text-align:right" | - |
|||
|} |
|||
</div> |
</div> |
||
{{fn note|1=1,2|2=1. Nominal debt. 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.}} |
|||
{{chunk|doc=snjra2xp9r|c=90|p=32}} |
|||
{{fn note|1=3|2=3. Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}} |
|||
====== Contractual maturity breakdown ====== |
|||
=== General Account Invested Assets === |
|||
* Contractual maturity breakdown: |
|||
** 2028: Senior debt: 0.5 |
|||
** 2030: Tier 2: 0.7; Senior debt: 0.9 |
|||
** 2031-2039: Tier 2: 1.5 |
|||
** ≥2040: Tier 2: 10.8; Senior debt: 0.5 |
|||
** Undated: Tier 1: 4.6; Tier 2: 0.7 |
|||
** o/w Grandfathered debt: |
|||
*** Tier 1: Undated: 1.4 |
|||
*** Tier 2: 2030: 0.7; ≥2040: 0.2 |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=96|p=33}} |
||
====== |
====== General Account invested assets duration gap ====== |
||
* [[Definition:Full year 2025|FY25]] Total General Account invested assets Duration gap at -0.4 year |
|||
* Economic maturity breakdown: |
|||
** [[Definition:Year 2026|2026]]: Tier 1: 0.1 |
|||
** 2027: Tier 2: 2.4 |
|||
** 2028: Tier 1: 0.1; Senior debt: 0.5 |
|||
** 2029: Tier 2: 2.0 |
|||
** 2030: Tier 2: 0.7; Senior debt: 0.9 |
|||
** 2031-2039: Tier 1: 0.4; Tier 2: 6.4; Senior debt: 1.5 |
|||
** ≥2040: Senior debt: 0.5 |
|||
** Undated: Tier 1: 4.0; Tier 2: 0.7 |
|||
** o/w Grandfathered debt: |
|||
*** Tier 1: 2026: 0.1; 2028: 0.1; 2031-2039: 0.4; Undated: 0.8 |
|||
*** Tier 2: 2030: 0.7; 2031-2039: 0.2 |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=97|p=33}} |
||
====== |
====== FY25 Total General Account invested assets: Euro 450 billion ====== |
||
<div style="overflow-x:auto"> |
|||
{{fn note|1=1|2=Nominal debt.}} |
|||
{| id="t34" class="wikitable" |
|||
{{fn note|1=2|2=In January 2026, AXA has called (i) the remaining T2 GF €139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.}} |
|||
|- |
|||
{{fn note|1=3|2=Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}} |
|||
| style="text-align:left" | Fixed income |
|||
|- |
|||
=== General Account Invested Assets === |
|||
| style="text-align:left" | Real estate |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=93|p=33}} |
|||
| style="text-align:left" | Infrastructure equity |
|||
====== General Account Invested Assets ====== |
|||
|- |
|||
| style="text-align:left" | Listed equities |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Private equity and hedge funds |
|||
Donut chart: [[Definition:Full year 2025|FY25]] Total General Account invested assets, Duration gap at -0.4 year. |
|||
|- |
|||
Total value in center: Euro 450 billion |
|||
| style="text-align:left" | Cash |
|||
Segments (with legend): |
|||
|- |
|||
- Fixed income |
|||
| style="text-align:left" | Policy loans |
|||
- Real estate |
|||
|} |
|||
- Infrastructure equity |
|||
- Listed equities |
|||
- Private equity and hedge funds |
|||
- Cash |
|||
- Policy loans |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=98|p=33}} |
||
====== Invested assets (100%) In Euro billion ====== |
====== Invested assets (100%) In Euro billion ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t35" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,237: | Line 1,682: | ||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|- |
|- |
||
| style="text-align:left" | Total Insurance Invested Assets {{fn ref|4}} |
|||
| style="text-align:right" | 450 |
|||
| style="text-align:right" | 100% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2= |
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}} |
||
{{fn note|1=2|2= |
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}} |
||
{{fn note|1=3|2= |
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}} |
||
{{fn note|1=4|2= |
{{fn note|1=4|2=Please refer to the financial supplement for more details.}} |
||
=== Structured and Private Credit assets === |
=== Structured and Private Credit assets === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=99|p=34}} |
||
====== Structured and Private Credit |
====== Invested assets (100%) by Total Structured and Private Credit Assets ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t36" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion |
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion |
||
! |
! style="text-align:right" | FY25 |
||
! |
! style="text-align:right" | % of total G/A{{fn ref|1}} portfolio |
||
! style="text-align: |
! style="text-align:right" | Comments |
||
|- |
|||
| style="text-align:left" | Residential Mortgages |
|||
| style="text-align:right" | 16 |
|||
| style="text-align:right" | 4% |
|||
| style="text-align:left" | - €6bn Dutch mortgages, NHG guaranteed<br/>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
|||
|- |
|||
| style="text-align:left" | CLO & ABS |
|||
| style="text-align:right" | 25 |
|||
| style="text-align:right" | 6% |
|||
| style="text-align:left" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
|||
|- |
|||
| style="text-align:left" | Infrastructure debt |
|||
| style="text-align:right" | 8 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
|||
|- |
|||
| style="text-align:left" | CRE debt |
|||
| style="text-align:right" | 8 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
|||
|- |
|||
| style="text-align:left" | Mid-Market lending |
|||
| style="text-align:right" | 10 |
|||
| style="text-align:right" | 2% |
|||
| style="text-align:left" | - Strong diversification with €8m average ticket<br/>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
|||
|- |
|||
| style="text-align:left" | Other |
|||
| style="text-align:right" | 2 |
|||
| style="text-align:right" | 0% |
|||
| style="text-align:left" | |
|||
|- |
|||
| style="text-align:left" | Total Structured and Private Credit Assets |
|||
| style="text-align:right" | 69 |
|||
| style="text-align:right" | 15% |
|||
| style="text-align:left" | o/w 54% participating |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>Residential Mortgages</td><td>16</td><td>4%</td><td>- €6bn Dutch mortgages, NHG guaranteed<br>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)</td></tr> |
|||
<tr><td>CLO & ABS</td><td>25</td><td>6%</td><td>- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)</td></tr> |
|||
<tr><td>Infrastructure debt</td><td>8</td><td>2%</td><td>- Skewed towards resilient industries (Telecom, Utilities, Transport)</td></tr> |
|||
<tr><td>CRE debt</td><td>8</td><td>2%</td><td>- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV</td></tr> |
|||
<tr><td>Mid-Market lending</td><td>10</td><td>2%</td><td>- Strong diversification with €8m average ticket<br>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation</td></tr> |
|||
<tr><td>Other</td><td>2</td><td>0%</td><td></td></tr> |
|||
<tr><td><strong>Total Structured and Private Credit Assets</strong></td><td><strong>69</strong></td><td><strong>15%</strong></td><td>o/w 54% participating</td></tr> |
|||
</table> |
|||
{{fn note|1=1|2=G/A: General Account}} |
{{fn note|1=1|2=G/A: General Account}} |
||
| Line 1,304: | Line 1,722: | ||
==== FY25 Fixed Income Reinvestment ==== |
==== FY25 Fixed Income Reinvestment ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=100|p=35}} |
||
====== |
====== Fixed income reinvestment portfolio ====== |
||
* Government bonds & related comprise 32% of the portfolio with an average rating of AA. |
|||
<div class="ed-chart-desc"> |
|||
* Investment grade credit comprises 40% of the portfolio with an average rating of A. |
|||
[Chart/image description:] |
|||
* ABS/CLO/IG fund financing comprises 21% of the portfolio. |
|||
Donut chart: [[Definition:Full year 2025|FY25]] Fixed Income Reinvestment, total Euro 57 billion. |
|||
* Below investment grade credit comprises 7% of the portfolio. |
|||
- Government bonds & related: 32% (Average rating: AA) |
|||
* The total reinvestment amount is EUR 57bn. |
|||
- Investment grade credit: 40% (Average rating: A) |
|||
- ABS/CLO/IG fund financing: 21% |
|||
- Below investment grade credit: 7% |
|||
</div> |
|||
==== FY25 Fixed Income Reinvestment Yield ==== |
==== FY25 Fixed Income Reinvestment Yield ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=101|p=35}} |
||
====== |
====== Fixed income reinvestment yield by public, private & structured fixed income ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t37" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: [[Definition:Full year 2025|FY25]] Fixed Income Reinvestment Yield. |
|||
- Public fixed income{{fn ref|1}} |
! style="text-align:left" | Public fixed income{{fn ref|1}} |
||
- Private & Structured fixed income{{fn ref|2}} |
! style="text-align:left" | Private & Structured fixed income{{fn ref|2}} |
||
- Total fixed income |
! class="col-s" style="text-align:right" | Total fixed income |
||
|- |
|||
| style="text-align:left" | 3.5% |
|||
| style="text-align:left" | 4.7% |
|||
| style="text-align:right" | 3.9% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=102|p=35}} |
|||
==== ▶ Euro 57 billion fixed income invested at 3.9% ==== |
|||
====== FY25 fixed income reinvestment yield ====== |
|||
{{chunk|doc=snjra2xp9r|c=98|p=35}} |
|||
====== Fixed income portfolio ====== |
|||
* EUR 57bn fixed income invested at 3.9% |
|||
* Average duration of 9 years |
* Average duration of 9 years |
||
* Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% |
* Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) |
||
** This includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY |
|||
* Gradual shift from alternative total return assets to Private & Structured credit |
* Gradual shift from alternative total return assets to Private & Structured credit |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=103|p=35}} |
||
====== |
====== FY25 Fixed Income Reinvestment Yield ====== |
||
{{fn note|1=1|2=Government and Corporate bonds and related.}} |
{{fn note|1=1|2=Government and Corporate bonds and related.}} |
||
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}} |
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}} |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=104|p=36}} |
||
====== |
====== Additional disclosures ====== |
||
* Additional P&C disclosures are on page 36. |
|||
* Additional IFRS17 disclosures are on page 41. |
|||
* Debt and Invested Assets disclosures are on page 31. |
|||
=== AXA XL Insurance – Large Commercial & Specialty business === |
|||
==== Well diversified across lines of business and geographies ==== |
|||
{{chunk|doc=snjra2xp9r|c=105|p=37}} |
|||
====== GWP by line of business ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t38" class="wikitable fintable" |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Casualty |
||
| style="text-align: |
| style="text-align:right" | 35% |
||
| style="text-align:right" | p.31 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Property |
||
| style="text-align: |
| style="text-align:right" | 29% |
||
| style="text-align:right" | p.36 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Specialty |
||
| style="text-align: |
| style="text-align:right" | 19% |
||
| style="text-align:right" | p.41 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Professional lines{{fn ref|1}} |
||
| style="text-align: |
| style="text-align:right" | 17% |
||
| style="text-align:right" | p.44 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=106|p=37}} |
|||
=== AXA XL Insurance – Large Commercial & Specialty business === |
|||
====== GWP by geography ====== |
|||
<div style="overflow-x:auto"> |
|||
==== Well diversified across lines of business and geographies ==== |
|||
{| id="t39" class="wikitable fintable" |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=101|p=37}} |
|||
| style="text-align:left" | Americas |
|||
====== Well diversified across lines of business and geographies ====== |
|||
| style="text-align:right" | 46% |
|||
|- |
|||
<div class="ed-chart-desc"> |
|||
| style="text-align:left" | Europe & APAC |
|||
[Chart/image description:] |
|||
| style="text-align:right" | 35% |
|||
Two donut charts showing [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] composition. |
|||
|- |
|||
| style="text-align:left" | UK & Lloyds |
|||
| style="text-align:right" | 19% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=102|p=37}} |
|||
====== FY25 GWP by line of business ====== |
|||
* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by line of business totaled USD 19bn: |
|||
** Casualty: 35% |
|||
** Property: 29% |
|||
** Specialty: 19% |
|||
** Professional lines: 17% |
|||
{{chunk|doc=snjra2xp9r|c=103|p=37}} |
|||
====== FY25 GWP by geography ====== |
|||
* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by geography totaled USD 19bn: |
|||
** Americas: 46% |
|||
** Europe & APAC: 35% |
|||
** UK & Lloyds: 19% |
|||
==== Leading market positions across lines ==== |
==== Leading market positions across lines ==== |
||
{{chunk|doc=snjra2xp9r|c=107|p=37}} |
|||
==== Top 3 globally ==== |
|||
====== Commercial lines market position ====== |
|||
* Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie. |
|||
{{chunk|doc=snjra2xp9r|c=104|p=37}} |
|||
====== P&C Commercial Lines ====== |
|||
* Multinational Programs are a key offering. |
|||
* Marine is a key offering. |
|||
* Fine Art & Specie is a key offering. |
|||
==== Managing the cycle to deliver consistent profitability ==== |
==== Managing the cycle to deliver consistent profitability ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=108|p=37}} |
||
====== Profitability |
====== Profitability vs. Ex-price growth by line of business ====== |
||
* Profitability Ex-price growth (%) |
* Profitability vs. Ex-price growth (%) |
||
** Professional lines: lower ex-price growth, lower profitability |
|||
** Casualty: medium ex-price growth, medium profitability |
|||
{{chunk|doc=snjra2xp9r|c=106|p=37}} |
|||
** Specialty (including Cyber): medium-high ex-price growth, medium-high profitability |
|||
====== Managing the cycle to deliver consistent profitability ====== |
|||
** Property: high ex-price growth, high profitability |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Bubble/scatter chart: lines of business plotted by Ex-price growth (%) on x-axis and Profitability on y-axis. |
|||
- Property: high profitability, moderate-to-high ex-price growth |
|||
- Specialty: mid profitability, mid ex-price growth |
|||
- Casualty: mid profitability, higher ex-price growth |
|||
- Professional lines: lower profitability, lower ex-price growth |
|||
Bubble sizes vary; exact axis values not printed. |
|||
@@ORIG_0@@ |
|||
</div> |
|||
=== P&C – Focus on Reserves === |
=== P&C – Focus on Reserves === |
||
| Line 1,434: | Line 1,833: | ||
==== Claims reserves ratio ==== |
==== Claims reserves ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=109|p=38}} |
||
====== |
====== Claims reserves ratio definition ====== |
||
* |
* Net undiscounted claims reserves / Net earned premiums. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=110|p=38}} |
||
====== Claims reserves ratio ====== |
====== Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t40" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: Claims reserves ratio, FY18 to [[Definition:Full year 2025|FY25]]. |
|||
! style="text-align:left" | |
|||
IFRS4: |
|||
! class="col-s" style="text-align:right" | FY18 |
|||
FY18: 179% |
|||
! class="col-s" style="text-align:right" | FY19 |
|||
FY19: 185% |
|||
! class="col-s" style="text-align:right" | FY20 |
|||
FY20: 193% |
|||
! class="col-s" style="text-align:right" | FY21 |
|||
FY21: 188% |
|||
! class="col-s" style="text-align:right" | FY22 |
|||
FY22: 189% |
|||
! class="col-s" style="text-align:right" | FY22 |
|||
IFRS17: |
|||
! class="col-s" style="text-align:right" | FY23 |
|||
FY22: 198% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
FY23: 195% |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
[[Definition:Full year 2024|FY24]]: 180% |
|||
|- |
|||
FY25: 175% |
|||
! style="text-align:left" | |
|||
! colspan="5" style="text-align:center" | IFRS4 |
|||
! colspan="4" style="text-align:center" | IFRS17 |
|||
|- |
|||
| style="text-align:left" | Claims reserves ratio |
|||
| style="text-align:right" | 179% |
|||
| style="text-align:right" | 185% |
|||
| style="text-align:right" | 193% |
|||
| style="text-align:right" | 188% |
|||
| style="text-align:right" | 189% |
|||
| style="text-align:right" | 198% |
|||
| style="text-align:right" | 195% |
|||
| style="text-align:right" | 180% |
|||
| style="text-align:right" | 175% |
|||
|} |
|||
</div> |
</div> |
||
==== Technical reserves ratio ==== |
==== Technical reserves ratio ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=111|p=38}} |
||
====== |
====== Technical reserves ratio definition ====== |
||
* |
* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=112|p=38}} |
||
====== Technical reserves ratio ====== |
====== Technical reserves ratio (Net undiscounted technical reserves/Net earned premiums) ====== |
||
<div |
<div style="overflow-x:auto"> |
||
{| id="t41" class="wikitable fintable" |
|||
[Chart/image description:] |
|||
|- |
|||
Bar chart: Technical reserves ratio, FY18 to [[Definition:Full year 2025|FY25]]. |
|||
! style="text-align:left" | |
|||
IFRS4: |
|||
! class="col-s" style="text-align:right" | FY18 |
|||
FY18: 213% |
|||
! class="col-s" style="text-align:right" | FY19 |
|||
FY19: 227% |
|||
! class="col-s" style="text-align:right" | FY20 |
|||
FY20: 233% |
|||
! class="col-s" style="text-align:right" | FY21 |
|||
FY21: 226% |
|||
! class="col-s" style="text-align:right" | FY22 |
|||
FY22: 227% |
|||
! class="col-s" style="text-align:right" | FY22 |
|||
IFRS17: |
|||
! class="col-s" style="text-align:right" | FY23 |
|||
FY22: 234% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
FY23: 232% |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
[[Definition:Full year 2024|FY24]]: 216% |
|||
|- |
|||
FY25: 210% |
|||
! style="text-align:left" | |
|||
@@ORIG_0@@ |
|||
! colspan="5" style="text-align:center" | IFRS4 |
|||
! colspan="4" style="text-align:center" | IFRS17 |
|||
|- |
|||
| style="text-align:left" | Technical reserves ratio |
|||
| style="text-align:right" | 213% |
|||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | 233% |
|||
| style="text-align:right" | 226% |
|||
| style="text-align:right" | 227% |
|||
| style="text-align:right" | 234% |
|||
| style="text-align:right" | 232% |
|||
| style="text-align:right" | 216% |
|||
| style="text-align:right" | 210% |
|||
|} |
|||
</div> |
</div> |
||
{{fn note|1=1|2=Includes net undiscounted claims reserves and unearned premium reserves.}} |
|||
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program === |
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=113|p=39}} |
||
====== |
====== Nat Cat Reinsurance Program ====== |
||
* All figures are in |
* All figures are in EUR. |
||
==== Insurance segment (occurrence protection) ==== |
|||
{{chunk|doc=snjra2xp9r|c=112|p=39}} |
|||
====== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ====== |
|||
==== Reinsurance segment (illustrative) ==== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Bar chart: [[Definition:Year 2026|2026]] Simplified Group Nat Cat Reinsurance Program — Capacity and Retention by peril, Insurance segment (occurrence protection) and Reinsurance segment (illustrative), in Euro. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=114|p=39}} |
||
====== |
====== Alternative Capital & Cat Bonds ====== |
||
* Alternative Capital & Cat Bonds |
|||
* Insurance segment (occurrence protection): |
|||
** EU Windstorm: Capacity EUR 4.0bn; Retention EUR 600m |
|||
** Europe Flood: Capacity EUR 2.1bn; Retention EUR 450m |
|||
** Europe Earthquake: Capacity EUR 2.1bn; Retention EUR 400m |
|||
** NA Hurricane: Capacity EUR 1.2bn; Retention EUR 600m |
|||
** NA Earthquake: Capacity EUR 1.2bn; Retention EUR 600m |
|||
** Per other perils: Retention EUR 400m |
|||
* Reinsurance segment (illustrative): includes Alternative Capital & Cat Bonds |
|||
* The program includes a EUR 1.0bn component. |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=115|p=39}} |
||
====== Capacity and Retention by peril ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t42" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | EU Windstorm |
|||
! class="col-s" style="text-align:right" | Europe Flood |
|||
! class="col-s" style="text-align:right" | Europe Earthquake |
|||
! class="col-s" style="text-align:right" | NA Hurricane |
|||
! class="col-s" style="text-align:right" | NA Earthquake |
|||
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}} |
|||
|- |
|||
| style="text-align:left" | Capacity |
|||
| style="text-align:right" | 4.0bn |
|||
| style="text-align:right" | 2.1bn |
|||
| style="text-align:right" | 2.1bn |
|||
| style="text-align:right" | 1.2bn |
|||
| style="text-align:right" | 1.2bn |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Retention |
|||
| style="text-align:right" | 600m |
|||
| style="text-align:right" | 450m |
|||
| style="text-align:right" | 400m |
|||
| style="text-align:right" | 600m{{fn ref|2}} |
|||
| style="text-align:right" | 600m{{fn ref|2}} |
|||
| style="text-align:right" | 400m |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=116|p=39}} |
|||
====== Retention levels ====== |
====== Retention levels ====== |
||
* |
* Stable retention levels maintained in [[Definition:Year 2026|2026]] as in 2025. |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=117|p=39}} |
||
====== Reinsurance segment (illustrative) ====== |
|||
====== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ====== |
|||
{{fn note|1=1|2=Excludes local reinsurance covers;}} |
{{fn note|1=1|2=Excludes local reinsurance covers;}} |
||
| Line 1,527: | Line 1,977: | ||
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 === |
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=118|p=40}} |
||
====== |
====== Nat Cat cost deviation ====== |
||
* |
* Nat Cat cost deviation in [[Definition:Year 2026|2026]] is presented in EUR billion (net of reinsurance). |
||
==== Group underlying earnings deviation to average Nat Cat charges in 2026 |
==== Group underlying earnings deviation to average Nat Cat charges in 2026 ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=119|p=40}} |
||
====== |
====== Nat Cat charges deviation ====== |
||
* The table presents Nat Cat charges deviation net of reinsurance, post-tax and pre-tax. |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
{{chunk|doc=snjra2xp9r|c=120|p=40}} |
|||
Bar chart: Group [[Definition:Underlying earnings|underlying earnings]] deviation to average Nat Cat charges in [[Definition:Year 2026|2026]]. |
|||
====== Deviation by percentile and return period ====== |
|||
The chart shows a distribution of outcomes from negative to positive deviation. |
|||
- More severe years (Negative deviation in ca. 40% of cases): |
|||
<div style="overflow-x:auto"> |
|||
- 1/20y (95th): €-1.2bn |
|||
{| id="t43" class="wikitable" |
|||
- 1/10y (90th): €-0.8bn |
|||
|- |
|||
- 1/5y (80th): €-0.4bn |
|||
! style="text-align:left" | Percentile |
|||
- Median (50th): €+0.1bn |
|||
! style="text-align:right" | Return period |
|||
- Less severe years (Positive deviation in ca. 60% of cases): |
|||
! style="text-align:right" | Deviation |
|||
- 1/5y (20th): €+0.5bn |
|||
|- |
|||
- 1/10y (10th): €+0.7bn |
|||
| style="text-align:left" | 95th |
|||
- 1/20y (5th): €+0.8bn |
|||
| style="text-align:right" | 1/20y (more severe) |
|||
| style="text-align:right" | €-1.2bn |
|||
|- |
|||
| style="text-align:left" | 90th |
|||
| style="text-align:right" | 1/10y |
|||
| style="text-align:right" | €-0.8bn |
|||
|- |
|||
| style="text-align:left" | 80th |
|||
| style="text-align:right" | 1/5y |
|||
| style="text-align:right" | €-0.4bn |
|||
|- |
|||
| style="text-align:left" | 50th |
|||
| style="text-align:right" | Median |
|||
| style="text-align:right" | €+0.1bn |
|||
|- |
|||
| style="text-align:left" | 20th |
|||
| style="text-align:right" | 1/5y |
|||
| style="text-align:right" | €+0.5bn |
|||
|- |
|||
| style="text-align:left" | 10th |
|||
| style="text-align:right" | 1/10y |
|||
| style="text-align:right" | €+0.7bn |
|||
|- |
|||
| style="text-align:left" | 5th |
|||
| style="text-align:right" | 1/20y |
|||
| style="text-align:right" | €+0.8bn |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=121|p=40}} |
|||
==== Average Expected Nat Cat charges net of reinsurance, pre-tax ==== |
|||
====== Nat Cat charges deviation ====== |
|||
* Negative deviation in approximately 40% of cases for more severe years. |
|||
{{chunk|doc=snjra2xp9r|c=118|p=40}} |
|||
* Positive deviation in approximately 60% of cases for less severe years. |
|||
====== Average Expected Nat Cat charges net of reinsurance, pre-tax ====== |
|||
==== Average Expected Nat Cat charges ==== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
{{chunk|doc=snjra2xp9r|c=122|p=40}} |
|||
Bar chart: Average Expected Nat Cat charges, 2025 vs [[Definition:Year 2026|2026]], in Euro billion. |
|||
====== Value & Estimated impact on GEP by year ====== |
|||
- 2025: 2.6 |
|||
- 2026: 2.7 |
|||
<div style="overflow-x:auto"> |
|||
- Estimated impact on GEP: |
|||
{| id="t44" class="wikitable" |
|||
- 2025: ca. 4.5% |
|||
|- |
|||
- 2026: ca. 4.5% |
|||
! style="text-align:left" | |
|||
! style="text-align:right" | 2025 |
|||
! style="text-align:right" | 2026 |
|||
|- |
|||
| style="text-align:left" | Value (€bn) |
|||
| style="text-align:right" | 2.6 |
|||
| style="text-align:right" | 2.7 |
|||
|- |
|||
| style="text-align:left" | Estimated impact on GEP |
|||
| style="text-align:right" | ca. 4.5% |
|||
| style="text-align:right" | ca. 4.5% |
|||
|} |
|||
</div> |
</div> |
||
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}} |
|||
{{chunk|doc=snjra2xp9r|c=119|p=40}} |
|||
====== Average Expected Nat Cat charges net of reinsurance, pre-tax ====== |
|||
{{chunk|doc=snjra2xp9r|c=123|p=41}} |
|||
{{fn note|1=1|2=1. Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).}} |
|||
====== Additional disclosures ====== |
|||
* Debt and Invested Assets are detailed on p.31 |
|||
{{chunk|doc=snjra2xp9r|c=120|p=41}} |
|||
* Additional P&C disclosures are on p.36 |
|||
* Additional IFRS17 disclosures are on p.41 |
|||
=== P&C – Margin Analysis === |
|||
==== Technical Result ==== |
|||
{{chunk|doc=snjra2xp9r|c=124|p=42}} |
|||
====== Pre-tax technical result ====== |
|||
* All figures are in EUR million (pre-tax). |
|||
{{chunk|doc=snjra2xp9r|c=125|p=42}} |
|||
====== Current Accident Year Undiscounted Technical Margin ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t45" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
|||
! class="col-m" style="text-align:right" | FY25 |
|||
! class="col-m" style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <strong>Current Accident Year Undiscounted Technical Margin</strong> |
||
| style="text-align: |
| style="text-align:right" | 2,778 |
||
| style="text-align:right" | |
| style="text-align:right" | +707 |
||
|- |
|||
| style="text-align:left" | Gross Earned Premiums |
|||
| style="text-align:right" | 57,656 |
|||
| style="text-align:right" | +6% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Current Accident Year Undiscounted Combined Ratio |
||
| style="text-align: |
| style="text-align:right" | 95.2% |
||
| style="text-align:right" | |
| style="text-align:right" | -1.0pt |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <em>o/w Nat Cats</em> |
||
| style="text-align: |
| style="text-align:right" | <em>3.4%</em> |
||
| style="text-align:right" | |
| style="text-align:right" | <em>-0.4pt</em> |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=126|p=42}} |
|||
=== P&C – Margin Analysis === |
|||
====== Current Accident Year Discounting by FY25 ====== |
|||
<div style="overflow-x:auto"> |
|||
{{chunk|doc=snjra2xp9r|c=121|p=42}} |
|||
{| id="t46" class="wikitable fintable" |
|||
====== P&C – Margin Analysis ====== |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <strong>Current Accident Year Discounting</strong> |
|||
| style="text-align:right" | 2,009 |
|||
| style="text-align:right" | +115 |
|||
|- |
|||
| style="text-align:left" | Discounting Ratio (in Combined Ratio points) |
|||
| style="text-align:right" | -3.5% |
|||
| style="text-align:right" | +0.0pt |
|||
|- |
|||
| style="text-align:left" | Current Accident Year Net Claims reserves |
|||
| style="text-align:right" | €19.0bn |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Duration |
|||
| style="text-align:right" | 4.0 years |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Current Accident Year Discount rate |
|||
| style="text-align:right" | 2.8% |
|||
| style="text-align:right" | |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=127|p=42}} |
|||
<div class="ed-chart-desc"> |
|||
====== Prior Years' Reserve Development (PYD) ====== |
|||
[Chart/image description:] |
|||
Bar chart: Technical Result and Financial Result for P&C, [[Definition:Full year 2025|FY25]], in Euro million (pre-tax). The chart shows a flow from Technical Result components (Current Accident Year Undiscounted Technical Margin, Current Accident Year Discounting, Prior Years' Reserve Development) to Financial Result components (Investment Income, Insurance Finance Expenses), culminating in [[Definition:Underlying earnings|Underlying Earnings]] before tax and Underlying Earnings. |
|||
<div style="overflow-x:auto"> |
|||
{| id="t47" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <strong>Prior Years' Reserve Development (PYD)</strong> |
|||
| style="text-align:right" | 622 |
|||
| style="text-align:right" | -341 |
|||
|- |
|||
| style="text-align:left" | PYD ratio |
|||
| style="text-align:right" | -1.1% |
|||
| style="text-align:right" | +0.7pt |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=128|p=42}} |
||
====== |
====== FY25 Current Accident Year discount rate sensitivity ====== |
||
* Current Accident Year |
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year discount rate changes: +25bps results in EUR +0.2bn; -25bps results in EUR -0.2bn. |
||
* Gross Earned Premiums: EUR 57,656m (+6%) |
|||
* Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt) |
|||
** of which Nat Cats: 3.4% (-0.4pt) |
|||
* Current Accident Year Discounting: EUR 2,009m (+EUR 115m) |
|||
* Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt) |
|||
* Current Accident Year Net Claims reserves: EUR 19.0bn |
|||
* Duration: 4.0 years |
|||
* Current Accident Year Discount rate: 2.8% |
|||
* Prior Years' Reserve Development (PYD): EUR 622m (-EUR 341m) |
|||
* PYD ratio: -1.1% (+0.7pt) |
|||
==== Financial Result ==== |
|||
{{chunk|doc=snjra2xp9r|c=123|p=42}} |
|||
====== Financial Result and Underlying Earnings ====== |
|||
{{chunk|doc=snjra2xp9r|c=129|p=42}} |
|||
* Investment Income: EUR 3,988m (+EUR 435m) |
|||
====== Pre-tax results ====== |
|||
* [[Definition:Full year 2025|FY25]] Average Assets: EUR 115bn |
|||
* Asset book yield: 3.5% |
|||
* FY25 Reinvestment yield: 4.3% |
|||
* Insurance Finance Expenses: EUR -1,358m (-EUR 235m) |
|||
* [[Definition:Full year 2024|FY24]] Reserves at locked-in rate: EUR 71bn |
|||
* Liability book yield: 1.9% |
|||
* [[Definition:Underlying earnings|Underlying Earnings]] before tax: EUR 8,040m (+EUR 681m) |
|||
* Tax: EUR -2,060m (-EUR 169m) |
|||
* Affiliates, Minority interests & Other: EUR -108m (-EUR 10m) |
|||
* Underlying Earnings: EUR 5,872m (+EUR 501m) |
|||
* Growth vs. FY24 (at constant [[Definition:Foreign exchange|FX]]): +9% |
|||
* All figures are in EUR million (pre-tax). |
|||
{{chunk|doc=snjra2xp9r|c=124|p=42}} |
|||
====== Discount Rate Sensitivity ====== |
|||
{{chunk|doc=snjra2xp9r|c=130|p=42}} |
|||
====== Investment income ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t48" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <strong>Investment Income</strong> |
|||
| style="text-align:right" | 3,988 |
|||
| style="text-align:right" | +435 |
|||
|- |
|||
| style="text-align:left" | FY25 Average Assets |
|||
| style="text-align:right" | €115bn |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Asset book yield |
|||
| style="text-align:right" | 3.5% |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | FY25 Reinvestment yield{{fn ref|1}} |
|||
| style="text-align:right" | 4.3% |
|||
| style="text-align:right" | |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=131|p=42}} |
|||
====== Insurance Finance Expenses ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t49" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <strong>Insurance Finance Expenses</strong> |
|||
| style="text-align:right" | -1,358 |
|||
| style="text-align:right" | -235 |
|||
|- |
|||
| style="text-align:left" | FY24 Reserves at locked-in rate |
|||
| style="text-align:right" | €71bn |
|||
| style="text-align:right" | |
|||
|- |
|||
| style="text-align:left" | Liability book yield |
|||
| style="text-align:right" | 1.9% |
|||
| style="text-align:right" | |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=132|p=42}} |
|||
====== Insurance finance expenses ====== |
|||
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year discount rate changes: |
|||
** +25bps: +EUR 0.2bn |
|||
** -25bps: -EUR 0.2bn |
|||
* 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn |
* 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn |
||
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount: |
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount: |
||
| Line 1,648: | Line 2,227: | ||
** -25bps: ~ EUR +50m |
** -25bps: ~ EUR +50m |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=133|p=42}} |
||
====== |
====== Underlying Earnings before tax and Underlying Earnings ====== |
||
<div style="overflow-x:auto"> |
|||
{| id="t50" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-m" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <strong>Underlying Earnings before tax</strong> |
|||
| style="text-align:right" | 8,040 |
|||
| style="text-align:right" | +681 |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | -2,060 |
|||
| style="text-align:right" | -169 |
|||
|- |
|||
| style="text-align:left" | Affiliates, Minority interests & Other |
|||
| style="text-align:right" | -108 |
|||
| style="text-align:right" | -10 |
|||
|- |
|||
| style="text-align:left" | <strong>Underlying Earnings</strong> |
|||
| style="text-align:right" | 5,872 |
|||
| style="text-align:right" | +501 |
|||
|- |
|||
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em> |
|||
| style="text-align:right" | |
|||
| style="text-align:right" | <em>+9%</em> |
|||
|} |
|||
</div> |
|||
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
||
| Line 1,656: | Line 2,264: | ||
=== L&H – Margin Analysis === |
=== L&H – Margin Analysis === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=134|p=43}} |
||
====== Scope impact ====== |
====== Scope impact ====== |
||
* |
* Scope impact is included. |
||
==== Technical Result ==== |
==== Technical Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=135|p=43}} |
||
====== Pre-tax |
====== Pre-tax technical result ====== |
||
* |
* Pre-tax technical result in EUR million |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=136|p=43}} |
||
====== Technical |
====== Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t51" class="wikitable fintable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 1,678: | Line 2,286: | ||
! class="col-s" style="text-align:right" | Change |
! class="col-s" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | Short-term Technical Margin |
| style="text-align:left" | <b>Short-term Technical Margin</b> |
||
| style="text-align:right" | 479 |
| style="text-align:right" | <b>479</b> |
||
| style="text-align:right" | +60 |
| style="text-align:right" | <b>+60</b> |
||
|- |
|- |
||
| style="text-align:left" | Gross Earned Premiums |
| style="text-align:left" | Gross Earned Premiums |
||
| Line 1,689: | Line 2,297: | ||
| style="text-align:right" | 97.2% |
| style="text-align:right" | 97.2% |
||
| style="text-align:right" | -0.1pts |
| style="text-align:right" | -0.1pts |
||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=137|p=43}} |
|||
====== Long-term Technical Margin by CSM release and Technical experience ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t52" class="wikitable fintable" |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! class="col-m" style="text-align:right" | FY25 |
|||
! class="col-m" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | <b>Long-term Technical Margin</b> |
|||
| style="text-align:right" | <b>2,804</b> |
|||
| style="text-align:right" | <b>+156</b> |
|||
|- |
|- |
||
| style="text-align:left" | CSM release |
| style="text-align:left" | CSM release |
||
| Line 1,703: | Line 2,323: | ||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=138|p=43}} |
|||
====== Technical result adjustments ====== |
|||
* The technical result includes the recapture of Laya. |
|||
{{chunk|doc=snjra2xp9r|c=139|p=43}} |
|||
====== FY25 CSM by sensitivities ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t53" class="wikitable" |
|||
|} |
|||
</div> |
|||
(in Euro billion)</caption> |
|||
<tr><th></th><th>[[Definition:Full year 2025|FY25]]</th></tr> |
|||
<tr><td><b>Baseline</b></td><td>33.3</td></tr> |
|||
<tr><td>Interest rates +50bps</td><td>-0.8</td></tr> |
|||
<tr><td>Interest rates -50bps</td><td>0.6</td></tr> |
|||
<tr><td>Sovereign spreads +50bps</td><td>-1.9</td></tr> |
|||
<tr><td>Sovereign spreads -50bps</td><td>1.9</td></tr> |
|||
<tr><td>Corporate spread +50bps</td><td>-0.8</td></tr> |
|||
<tr><td>Corporate spread -50bps</td><td>0.7</td></tr> |
|||
<tr><td>Equities +25%</td><td>1.8</td></tr> |
|||
<tr><td>Equities -25%</td><td>-2.2</td></tr> |
|||
</table> |
|||
==== Financial Result ==== |
==== Financial Result ==== |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=140|p=43}} |
||
====== Pre-tax |
====== Pre-tax result ====== |
||
* |
* Pre-tax result (in EUR million, pre-tax) |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=141|p=43}} |
||
====== Investment |
====== Investment Income (non-VFA only) ====== |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t54" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:right" | FY25 |
||
! |
! style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | Investment Income (non-VFA only) |
| style="text-align:left" | <b>Investment Income (non-VFA only)</b> |
||
| style="text-align:right" | 2,484 |
| style="text-align:right" | <b>2,484</b> |
||
| style="text-align:right" | -1 |
| style="text-align:right" | <b>-1</b> |
||
|- |
|- |
||
| style="text-align:left" | FY25 Average Assets |
| style="text-align:left" | FY25 Average Assets |
||
| Line 1,736: | Line 2,381: | ||
| style="text-align:right" | 3.8% |
| style="text-align:right" | 3.8% |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=142|p=43}} |
|||
====== Insurance Finance Expenses (non-VFA only) ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t55" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | |
|||
! style="text-align:right" | FY25 |
|||
! style="text-align:right" | Change |
|||
|- |
|- |
||
| style="text-align:left" | Insurance Finance Expenses (non-VFA only) |
| style="text-align:left" | <b>Insurance Finance Expenses (non-VFA only)</b> |
||
| style="text-align:right" | -1,538 |
| style="text-align:right" | <b>-1,538</b> |
||
| style="text-align:right" | -9 |
| style="text-align:right" | <b>-9</b> |
||
|- |
|- |
||
| style="text-align:left" | FY24 Reserves at locked-in rate |
| style="text-align:left" | FY24 Reserves at locked-in rate |
||
| Line 1,751: | Line 2,408: | ||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=143|p=43}} |
||
====== |
====== Underlying earnings before tax and underlying earnings ====== |
||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Flow diagram showing the summation of margins to [[Definition:Underlying earnings|Underlying Earnings]]: |
|||
- Short-term Technical Margin (479) [Incl. recapture of Laya] |
|||
- Plus (+) Long-term Technical Margin (2,804) |
|||
- Plus (+) Investment Income (non-VFA only) (2,484) |
|||
- Plus (+) Insurance Finance Expenses (non-VFA only) (-1,538) |
|||
- Equals (=) Underlying Earnings before tax (4,229) |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=132|p=43}} |
|||
====== Financial Result ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t56" class="wikitable" |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:right" | FY25 |
||
! |
! style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | Underlying Earnings before tax |
| style="text-align:left" | <b>Underlying Earnings before tax</b> |
||
| style="text-align:right" | 4,229 |
| style="text-align:right" | <b>4,229</b> |
||
| style="text-align:right" | +205 |
| style="text-align:right" | <b>+205</b> |
||
|- |
|- |
||
| style="text-align:left" | Tax |
| style="text-align:left" | Tax |
||
| Line 1,786: | Line 2,430: | ||
| style="text-align:right" | -51 |
| style="text-align:right" | -51 |
||
|- |
|- |
||
| style="text-align:left" | Underlying Earnings |
| style="text-align:left" | <b>Underlying Earnings</b> |
||
| style="text-align:right" | 3,501 |
| style="text-align:right" | <b>3,501</b> |
||
| style="text-align:right" | +219 |
| style="text-align:right" | <b>+219</b> |
||
|- |
|- |
||
| style="text-align:left" | Growth vs. FY24 (at constant FX) |
| style="text-align:left" | <i>Growth vs. FY24 (at constant FX)</i> |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
| style="text-align:right" | +7% |
| style="text-align:right" | +7% |
||
| Line 1,796: | Line 2,440: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
|||
{{chunk|doc=snjra2xp9r|c=133|p=43}} |
|||
====== FY25 CSM by sensitivities ====== |
|||
{{chunk|doc=snjra2xp9r|c=144|p=44}} |
|||
<div style="overflow-x:auto"> |
|||
====== Additional disclosures ====== |
|||
{| id="t15" class="wikitable fintable" |
|||
|- |
|||
| style="text-align:left" | Baseline |
|||
| style="text-align:right" | 33.3 |
|||
|- |
|||
| style="text-align:left" | Interest rates +50bps |
|||
| style="text-align:right" | -0.8 |
|||
|- |
|||
| style="text-align:left" | Interest rates -50bps |
|||
| style="text-align:right" | 0.6 |
|||
|- |
|||
| style="text-align:left" | Sovereign spreads +50bps |
|||
| style="text-align:right" | -1.9 |
|||
|- |
|||
| style="text-align:left" | Sovereign spreads -50bps |
|||
| style="text-align:right" | 1.9 |
|||
|- |
|||
| style="text-align:left" | Corporate spread +50bps |
|||
| style="text-align:right" | -0.8 |
|||
|- |
|||
| style="text-align:left" | Corporate spread -50bps |
|||
| style="text-align:right" | 0.7 |
|||
|- |
|||
| style="text-align:left" | Equities +25% |
|||
| style="text-align:right" | 1.8 |
|||
|- |
|||
| style="text-align:left" | Equities -25% |
|||
| style="text-align:right" | -2.2 |
|||
|} |
|||
</div> |
|||
* Debt and Invested Assets disclosures are on p.31. |
|||
{{fn note|1=1|2=1. Reinvestment yield on fixed income assets.}} |
|||
* Additional P&C disclosures are on p.36. |
|||
* Additional IFRS17 disclosures are on p.41. |
|||
=== Expanding AXA's role in society: AXA for Progress Index === |
|||
{{chunk|doc=snjra2xp9r|c=134|p=44}} |
|||
====== Financial results ====== |
|||
{{chunk|doc=snjra2xp9r|c=145|p=45}} |
|||
* The financial results are presented on a reported basis. |
|||
====== Target and 2025 Result by Global Investor, Global Insurer, and Company ====== |
|||
{{chunk|doc=snjra2xp9r|c=135|p=44}} |
|||
====== Debt and Invested Assets ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| id=" |
{| id="t57" class="wikitable" |
||
|- |
|- |
||
! colspan="2" style="text-align:center" | As a GLOBAL INVESTOR |
|||
! colspan="2" style="text-align:center" | As a GLOBAL INSURER |
|||
! colspan="2" style="text-align:center" | As a COMPANY |
|||
|- |
|||
| style="text-align:left" | 2. |
|||
| style="text-align:left" | Additional P&C disclosures |
|||
| style="text-align:right" | p.36 |
|||
|- |
|||
| style="text-align:left" | 3. |
|||
| style="text-align:left" | Additional IFRS17 disclosures |
|||
| style="text-align:right" | p.41 |
|||
|- |
|||
| style="text-align:left" | 4. |
|||
| style="text-align:left" | Sustainability |
|||
| style="text-align:right" | p.44 |
|||
|} |
|||
</div> |
|||
=== Expanding AXA's role in society: AXA for Progress Index === |
|||
{{chunk|doc=snjra2xp9r|c=136|p=45}} |
|||
====== Climate transition financing & community resilience financing by Target ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t17" class="wikitable" |
|||
|- |
|- |
||
! style="text-align:left" | Target |
! style="text-align:left" | Target |
||
! style="text-align:right" | 2025 Result |
! style="text-align:right" | 2025 Result |
||
! style="text-align:left" | Target |
|||
|- |
|||
! style="text-align:right" | 2025 Result |
|||
| style="text-align:right" | €6.4bn |
|||
|- |
|||
| style="text-align:left" | >€500m{{fn ref|2}} in community resilience financing per year |
|||
| style="text-align:right" | €1.4bn |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=137|p=45}} |
|||
====== Target by 2025 result ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t18" class="wikitable" |
|||
|- |
|||
! style="text-align:left" | Target |
! style="text-align:left" | Target |
||
! style="text-align:right" | 2025 Result |
! style="text-align:right" | 2025 Result |
||
|- |
|- |
||
| style="text-align:left" | €5bn{{fn ref|2}} in climate transition financing per year |
|||
| rowspan="2" style="text-align:right" | €6.4bn |
|||
| style="text-align:left" | €6bn{{fn ref|3}} in P&C GWP to support transition underwriting (cumulative 2024-2026) |
| style="text-align:left" | €6bn{{fn ref|3}} in P&C GWP to support transition underwriting (cumulative 2024-2026) |
||
| style="text-align:right" | €4.6bn |
| style="text-align:right" | €4.6bn |
||
| style="text-align:left" | >80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}} AXA Group employees trained on climate adaptation by 2026 |
|||
| style="text-align:right" | 46,420 |
|||
|- |
|- |
||
| style="text-align:left" | > |
| style="text-align:left" | >€500m{{fn ref|2}} in community resilience financing per year |
||
| style="text-align:right" | |
| style="text-align:right" | >20,000{{fn ref|4}} climate adaptation solutions & services (cumulative 2024-2026) Target revised in 2025 |
||
| style="text-align:left" | 19,698 Cumulative 2024-2025 |
|||
| style="text-align:right" | Contribute to Net-Zero -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030 in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}} |
|||
| style="text-align:left" | -64% Reduction against 2019 |
|||
|- |
|- |
||
| style="text-align:left" | |
|||
| style="text-align:right" | €1.4bn |
|||
| style="text-align:left" | >20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}} inclusive insurance customers by 2026 |
| style="text-align:left" | >20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}} inclusive insurance customers by 2026 |
||
| style="text-align:right" | 20.6m |
| style="text-align:right" | 20.6m |
||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=138|p=45}} |
|||
====== Target by 2025 Result ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t19" class="wikitable fintable" |
|||
|- |
|||
! style="text-align:left" | Target |
|||
! class="col-m" style="text-align:right" | 2025 Result |
|||
|- |
|||
| style="text-align:left" | >80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}} AXA Group employees trained on climate adaptation by 2026 |
|||
| style="text-align:right" | 46,420 |
|||
|- |
|||
| style="text-align:left" | Contribute to Net-Zero -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030 in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}} |
|||
| style="text-align:right" | -64% Reduction against 2019 |
|||
|- |
|||
| style="text-align:left" | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 |
| style="text-align:left" | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 |
||
| style="text-align:right" | 56% |
| style="text-align:right" | 56% |
||
| Line 1,932: | Line 2,501: | ||
=== Sustainability Performance & Ratings === |
=== Sustainability Performance & Ratings === |
||
{{chunk|doc=snjra2xp9r|c=146|p=46}} |
|||
==== S&P Global ==== |
|||
====== Sustainability ratings ====== |
|||
* Dow Jones Best-in-Class Europe & World indices percentile: 97th in 2025 |
|||
{{chunk|doc=snjra2xp9r|c=139|p=46}} |
|||
* MSCI score: AAA in 2025 |
|||
====== S&P Global ESG ratings ====== |
|||
* CDP score: B in 2025 |
|||
* Sustainalytics ESG Risk Rating: 17.0 (Low risk) in 2025 |
|||
* FTSE4Good Index Series score: 4.3/5 in 2025 |
|||
{{chunk|doc=snjra2xp9r|c=147|p=46}} |
|||
* Dow Jones Best-in-Class Europe & World indices percentile: 97 |
|||
====== Sustainability Performance & Ratings ====== |
|||
* Score: AAA |
|||
* ESG Risk Rating: 17.0 (Low risk) |
|||
* FTSE4Good Index Series score: 4.3/5 |
|||
{{fn note|1=1|2=The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.}} |
|||
==== QCDP ==== |
|||
{{chunk|doc=snjra2xp9r|c=140|p=46}} |
|||
====== QCDP score ====== |
|||
* 2025 QCDP score: B |
|||
{{chunk|doc=snjra2xp9r|c=141|p=46}} |
|||
====== QCDP ====== |
|||
{{fn note|1=th 1|2=The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.}} |
|||
=== Scope === |
=== Scope === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=148|p=47}} |
||
====== Scope |
====== Scope of activities by geography and segment ====== |
||
* France: includes insurance activities, banking activities, and holding. |
* France: includes insurance activities, banking activities, and holding. |
||
* Europe: includes Switzerland (insurance activities) |
* Europe: includes Switzerland (insurance activities); Germany (insurance activities and holding); Belgium and Luxembourg (insurance activities and holding); United Kingdom and Ireland (insurance activities and holding); Spain (insurance activities and holdings); Italy (insurance activities); Prima (insurance activities); and AXA Life Europe (insurance activities). |
||
* |
* AXA XL: includes insurance and reinsurance activities and holding. |
||
* Asia, Africa & EME-LATAM: |
* Asia, Africa & EME-LATAM: |
||
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated. |
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated. |
||
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) are consolidated under the equity method and contribute to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income. |
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024, and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income. |
||
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated. |
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) are fully consolidated. |
||
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated. |
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated. |
||
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income. |
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income. |
||
** |
** EME-LATAM: AXA Mediterranean Holdings. |
||
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings. |
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings. |
||
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated. |
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method. |
||
* AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method. |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=149|p=47}} |
||
====== Accounting standards ====== |
====== Accounting standards ====== |
||
* All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023. |
* All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified. |
||
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4. |
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4. |
||
=== Glossary === |
=== Glossary === |
||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=150|p=48}} |
||
====== Glossary of terms ====== |
====== Glossary of financial terms ====== |
||
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%. |
|||
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders. |
|||
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period. |
|||
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force. |
|||
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow. |
|||
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). |
|||
** Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities). |
|||
* New Business Value (NBV): the value of newly issued contracts during the current year. |
|||
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests. |
|||
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided. |
|||
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP. |
|||
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. |
|||
** Operating variance is net of reinsurance. |
|||
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. |
|||
** PVEP is discounted at the reference interest rate and PVEP is Group share. |
|||
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses. |
|||
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance. |
|||
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0% |
|||
=== February 26, 2026 Thank you Full Year 2025 Earnings === |
|||
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders |
|||
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period |
|||
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force |
|||
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow |
|||
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) |
|||
** Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) |
|||
* New Business Value (NBV): the value of newly issued contracts during the current year |
|||
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests |
|||
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided |
|||
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP |
|||
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes |
|||
** Operating variance is net of reinsurance |
|||
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term |
|||
** PVEP is discounted at the reference interest rate and PVEP is Group share |
|||
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses |
|||
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance |
|||
=== Thank you === |
|||
{{chunk|doc=snjra2xp9r|c= |
{{chunk|doc=snjra2xp9r|c=151|p=49}} |
||
====== |
====== Earnings presentation details ====== |
||
* [[Definition:Full year 2025|Full Year 2025]] Earnings |
* [[Definition:Full year 2025|Full Year 2025]] Earnings presentation was on February 26, [[Definition:Year 2026|2026]]. |
||
Revision as of 14:36, 22 July 2026
| Document info | |
|---|---|
| Document ID | snjra2xp9r |
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Earnings presentation |
| Document name | AXA Full Year 2025 Results Presentation |
| Publication date | 2026-02-26 |
| Language | English |
| Pages | 49 |
| Source | original URL |
| Transcript | wiki page |
| Data | data page |
This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
Full Year 2025 Earnings Presentation
[c. 1; p. 1]
Presentation date
- The presentation date is February 26, 2026.
Full Year 2025 Earnings
[c. 2; p. 2]
Legal and cautionary statements
- Certain statements in the presentation are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and other non-historical information.
- Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could".
- Statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group’s current strategic plan.
- These statements are based on Management’s current views and intentions and are subject to change.
- Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA’s control, which can cause actual results to differ materially.
- Each forward-looking statement is valid only at the date of the presentation.
- For important factors, risks, and uncertainties affecting AXA’s business and/or results, refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2024 (the “2024 Universal Registration Document”).
- AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations.
- The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position.
- These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies.
- Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
- "Underlying earnings", UEPS (“underlying earnings per share”), “underlying return on equity”, “combined ratio”, and “debt gearing” are APMs as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015.
- AXA provides a reconciliation of APMs to related financial statement items and/or their calculation methodology in its Activity Report as of December 31, 2025 (“AXA’s 2025 Activity Report”), under the heading “USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES”.
- Further information on non-GAAP financial measures is available in the Glossary in AXA’s 2025 Activity Report.
- AXA’s Activity Report as of December 31, 2025, is available on the AXA Group website (www.axa.com).
- AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors.
[c. 3; p. 3]
Presentation structure and speakers
- The presentation includes "FY25 Highlights" on page 04, presented by Thomas Buberl, Group CEO.
- "FY25 Business Performance" is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
- "FY25 Financial Performance" is on page 13, presented by Alban de Mailly Nesle, Group CFO.
FY25 Highlights
[c. 4; p. 4]
Group CEO
- Thomas Buberl is the Group CEO.
Full Year 2025 – Excellent performance
[c. 5; p. 5]
Financial performance FY25
- Revenues +6% vs. FY24
- Underlying EPS +8% vs. FY24
- ROE 16% FY25
- Solvency II ratio 224% FY25
[c. 6; p. 5]
- Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual share buyback
- Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
[c. 7; p. 5]
Full Year 2025 – Excellent performance
Executing the plan on growth, margin and efficiency
[c. 8; p. 6]
Underlying earnings by FY24, FY25, Change
| FY24 | FY25 | Change | |
|---|---|---|---|
| Underlying earnings | 8.1 | 8.4 | +6% |
| Underlying earnings excluding AXA IM | +9% |
- High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
- Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
- Scaling the business: Continued investments in growth and technology
- Consistent earnings growth while enhancing reserve prudence
Diversified franchise, well positioned in an attractive industry
Secular trends fueling demand across businesses
[c. 9; p. 7]
| Segment | Share |
|---|---|
| Life | 33% |
| Health | 17% |
| Large & Specialty | 17% |
| Retail | 17% |
| SME & Mid-market | 16% |
[c. 10; p. 7]
Secular trends fueling demand
- Protection gaps and emerging corporate risks are driving demand.
- Demographics are driving demand for private retirement and healthcare.
Our right to win
[c. 11; p. 7]
Competitive advantages
- Leading brand and high customer NPS
- Strong and diversified distribution
- Technical expertise in pricing and underwriting risks
- Scale offering cost advantage
[c. 12; p. 7]
Our right to win
Laying the foundation for the next plan
[c. 13; p. 8]
Strategic priorities
- Clear tech and AI roadmap
- Driving efficiency
- Enhancing capital allocation discipline
- Building resilience
- Confidence in sustaining earnings growth
FY25 Business Performance
[c. 14; p. 9]
Executive roles
- Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
Strong delivery across our businesses
[c. 15; p. 10]
| Gross written premiums | Underlying earnings |
|---|
France (27% of total GWP1)+6% to €31bn+7% to €2.2bn Europe (38% of total GWP1)+6% to €43bn+9% to €3.5bn AXA XL (17% of total GWP1)+4% to €19bn+9% to €1.9bn Asia, Africa & EME-LATAM (18% of total GWP1)+13% to €20bn+6% to €1.5bn
P&C – Strong margins, confidence in sustaining growth
[c. 16; p. 11]
- Gross Written Premiums (GWP) were EUR 58bn.
- GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty).
[c. 17; p. 11]
2025 and Beyond
| 2025 | Beyond 2025 | |
|---|---|---|
| Retail and SME & Mid-market | Growing volumes while expanding margins | Investing to improve customer retention & expanding distribution footprint |
| AXA XL (Large & Specialty) | Profitable growth with stable margins | Capitalizing on attractive growth opportunities and continued cycle management |
[c. 18; p. 11]
Underlying earnings and efficiency
- Underlying earnings: +9% to EUR 5.9bn
- Continued progress on efficiency
- Higher investment income
- Data & AI to further enhance customer experience & technical excellence
[c. 19; p. 11]
P&C – Strong margins, confidence in sustaining growth
L&H – Good momentum, well positioned to capture growth opportunities
[c. 20; p. 12]
GWP by Short-term and Long-term
| Short-term | Long-term |
2025 Beyond 2025
[c. 21; p. 12]
Strategic priorities for 2025 and Beyond 2025
- Long-term business:
- 2025: Accelerating net flows in Savings at attractive margins
- Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for customers
- Short-term business:
- 2025: Growing technical results while absorbing Mexico VAT impact
- Beyond 2025: Capitalizing on demand for health & protection while further improving margins
- Underlying earnings +7% to EUR 3.5bn
- Focus on cost reduction
- Increasing penetration of Protection riders in Savings offerings
- Leveraging AI to reduce claims leakage & improve customer outcomes in Health
[c. 22; p. 12]
2025 Beyond 2025
FY25 Financial Performance
[c. 23; p. 13]
Group CFO
- Alban de Mailly Nesle is the Group CFO.
P&C – Continued disciplined growth
[c. 24; p. 14]
Currency notation
- All figures are in EUR billion.
GWP & Other Revenues
[c. 25; p. 14]
GWP & other revenues by lines of business
| FY24 | FY25 | Change | o/w pricing1 | o/w volume2 | |
|---|---|---|---|---|---|
| Commercial lines | 56.5 | 35.8 | +4% | +2% | +2% |
| AXA XL Reinsurance | 2.6 | +8% | +0.3% | +7% | |
| Retail lines | 19.7 | +7% | +5% | +2% | |
| Total | 56.5 | 58.0 | +5% |
[c. 26; p. 14]
Commercial lines growth drivers
- Continued pricing momentum and volume growth in Mid-market and SME.
- Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance.
- Growth supported by alternative capital.
- Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25).
[c. 27; p. 14]
GWP & Other Revenues
P&C – Delivering further margin expansion while enhancing reserve prudence
Combined ratio
[c. 28; p. 15]
Combined ratio
| FY24 | FY25 | |
|---|---|---|
| Combined ratio (total) | 91.0% | 90.6% |
| Undiscounted CY loss ratio (ex Nat Cat) | 67.4% | 67.0% |
| Expense ratio | 25.0% | 24.8% |
| Nat Cat | 3.8% | 3.4% |
| Prior year reserve development | -1.6% | -1.1% |
| Discount | -3.6% | -3.5% |
[c. 29; p. 15]
Combined ratio drivers
- Undiscounted current year loss ratio improved, excluding Nat Cat.
- Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
- AXA XL Insurance margins stable at attractive levels, reflecting disciplined cycle management.
- Expense ratio improved due to efficiency measures, while continuing investment in growth initiatives and technology.
[c. 30; p. 15]
Nat Cat and reserve management
- Nat Cat charges were below the normalized load.
- Lower reliance on prior year reserve development.
- Reserve prudence enhanced during a favorable year.
P&C – Earnings growth from higher underwriting and financial result
[c. 31; p. 16]
P&C earnings growth
- P&C earnings grew by EUR 0.2bn to EUR 7.6bn in 2023.
- This growth was driven by a higher underwriting result and a higher financial result.
[c. 32; p. 16]
Underlying earnings waterfall by step
| Step | Value |
|---|---|
| FY24 | 5,510 |
| Volume growth | +292 |
| Margin improvement | +189 |
| Investment income | +435 |
| Insurance finance expenses | -235 |
| Tax | -169 |
| Affiliates, FX & other | -150 |
| FY25 | 5,872 |
[c. 33; p. 16]
P&C earnings growth
- P&C earnings grew +9%.
- Growth was driven by the underwriting result.
- Growth was driven by the financial result.
[c. 34; p. 16]
Underwriting result drivers
- The underwriting result improved due to strong volume growth.
- The underwriting result improved due to an enhanced all-year combined ratio.
- The underwriting result improved while enhancing reserve prudence.
[c. 35; p. 16]
Financial result drivers
- Investment income increased due to higher volumes.
- Investment income increased due to better reinvestment yields on fixed income assets.
- The unwind of discount of claims reserves was higher, in line with guidance.
[c. 36; p. 16]
Forex impact
- There was an unfavorable forex impact, notably due to USD depreciation vs. EUR.
[c. 37; p. 16]
P&C – Earnings growth from higher underwriting and financial result
[c. 38; p. 17]
Life GWP & Other Revenues
| FY24 | FY25 | Growth | |
|---|---|---|---|
| Protection | 17.3 | +11% | |
| Unit-Linked | 9.3 | +13% | |
| Capital light G/A | 9.0 | +7% | |
| Traditional G/A | 1.9 | -7% | |
| Total | 34.5 | 37.5 | +9% |
[c. 39; p. 17]
Health GWP & other revenues by individual and group
| FY24 | FY25 | Growth | |
|---|---|---|---|
| Individual | 10.5 | +6% | |
| Group | 8.5 | +4% | |
| Total | 17.5 | 19.0 | +5% |
[c. 40; p. 17]
Flow by segment
| Segment | Flow (€bn) |
|---|---|
| Protection | +4.9 |
| Health | +2.7 |
| Unit-Linked | +1.5 |
| Capital light G/A | +1.2 |
| Traditional G/A | -5.0 |
[c. 41; p. 17]
- Employee Benefits premiums: EUR 12.9bn (+4% vs. FY24)
[c. 42; p. 17]
Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[c. 43; p. 18]
Currency notation
- All figures are in EUR billion.
[c. 44; p. 18]
PVEP by business mix
| FY24 | FY25 | |
|---|---|---|
| Protection & Health | 50.9 | 31.4 |
| Unit-Linked | 8.5 | |
| Capital-light G/A | 7.8 | |
| Traditional G/A | 1.7 | |
| Total | 50.9 | 49.4 |
| Change | -2% | |
| Protection & Health change | -4% | |
| Unit-Linked change | +18% | |
| Capital-light G/A change | -10% | |
| Traditional G/A change | -10% |
[c. 45; p. 18]
NB CSM (pre-tax)
| FY24 | FY25 | |
|---|---|---|
| NB CSM (pre-tax) | 2.2 | 2.2 |
| Change | +3% |
[c. 46; p. 18]
NBV (post-tax) by FY
| FY24 | FY25 | |
|---|---|---|
| NBV (post-tax) | 2.3 | 2.2 |
| Change | stable | |
| NBV margin | 4.4% | 4.5% |
[c. 47; p. 18]
PVEP, NB CSM, and NBV performance
- PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes.
- NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
- NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
[c. 48; p. 18]
Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
Life & Health – Growth in new business driving Normalized CSM growth
[c. 49; p. 19]
New business CSM
- New business CSM: EUR 2.2bn
Contractual Service Margin rollforward
[c. 50; p. 19]
Contractual Service Margin rollforward (In Euro billion)
| FY24 | New business CSM | Underlying return on in-force | CSM release | Economic variance | Operating variance | Affiliates, FX & other | FY25 |
|---|
33.6+2.2+1.3-3.0+0.6-0.3-1.433.0 o/w Life: 25.825.4 o/w Health: 7.77.6
[c. 51; p. 19]
Normalized CSM growth and drivers
- Normalized CSM growth: +2%
- Normalized CSM up +2%, with CSM release growth reflecting better margins
- New business CSM growth impacted by higher rates
- Economic variance reflects government spreads tightening and positive equity market returns
- Operating variance driven by better margins and net flows, more than offset by a reduction in the duration of Group Life business in Switzerland
- FX impact mainly from JPY and HKD depreciation
[c. 52; p. 19]
Contractual Service Margin rollforward
Life & Health – Strong momentum in both short-term and long-term business
[c. 53; p. 20]
Life & Health business overview
- All figures are in EUR million.
Underlying Earnings
[c. 54; p. 20]
Underlying Earnings (In Euro million)
| FY24 | Short-term technical margin | Long-term result incl. CSM release | Financial result | Tax, FX and others | FY25 | |
|---|---|---|---|---|---|---|
| Short-term technical margin | 415 | +60 | 479 | |||
| Long-term result incl. CSM release | 2,680 | +156 | 2,804 | |||
| Financial result | 975 | -11 | 946 | |||
| Tax & others | -748 | -27 | -728 | |||
| Total | 3,323 | 3,501 |
[c. 55; p. 20]
Underlying Earnings
- Underlying Earnings: +7%
[c. 56; p. 20]
in billions
| FY24 | FY25 | Change at constant FX | |
|---|---|---|---|
| o/w Life | 2.6 | 2.7 | +4% vs. FY24 |
| o/w Health | 0.7 | 0.8 | +17% vs. FY24 |
[c. 57; p. 20]
Technical Margin and Long-Term Results
- Short-term technical margin was strong, reflecting underwriting and claims initiatives.
- Underwriting and claims initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn).
- Long-term results were higher due to an increase in CSM release (+8%).
- The increase in CSM release reflects growth in the reserve base, including from favorable equity market performance, and better margins.
[c. 58; p. 20]
Underlying Earnings
Growth in net income reflecting higher earnings & the gain from the sale of AXA IM
[c. 59; p. 21]
Net income by business line
| FY24 | FY25 | Change | |
|---|---|---|---|
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | - |
| Underlying earnings | 8.1 | 8.4 | +6% |
| Non-financial flows | -0.5 | +2.1 | |
| o/w capital gains from AXA IM disposal | - | +2.2 | |
| Financial flows (incl. RCG) | +0.3 | -0.7 | |
| Net income | 7.9 | 9.8 | +26% |
[c. 60; p. 21]
Underlying earnings and net income drivers
- Underlying earnings showed strong performance from insurance businesses.
- Holding cost was stable and is expected to remain at the current level in 2026.
- Net income was higher, mainly reflecting higher underlying earnings and the gain from the sale of AXA IM.
- Lower financial flows reflected an unfavorable forex impact.
[c. 61; p. 21]
- Underlying earnings per share are presented in Euro.
[c. 62; p. 21]
| FY24 | FY25 | Change |
|---|---|---|
| 3.59 | 3.86 | +8% |
[c. 63; p. 21]
Underlying EPS growth drivers
- Underlying EPS growth: +6% from earnings growth
- Underlying EPS growth: +3% from capital management
- Underlying EPS growth: -2% from forex
- Underlying EPS growth: -1% from temporary earnings dilution due to AXA IM sale, related to the timing of anti-dilutive share buyback
[c. 64; p. 21]
[c. 65; p. 22]
| FY24 | HY25 | FY25 | |
|---|---|---|---|
| Total | 49.9 | 45.5 | 47.2 |
| SHE (excl. OCI) | 58.0 | 52.7 | 54.0 |
| Net OCI | -8.1 | -7.2 | -6.8 |
| SHE (excl. OCI & undated subordinated debt) | 53.2 | 47.0 | 49.4 |
| Debt gearing | 20.6% | 23.4% | 22.3% |
| Underlying ROE | 15.2% | 17.5% | 16.0% |
[c. 66; p. 22]
| FY24 to FY25 | HY25 to FY25 | |
|---|---|---|
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | 1.3 | 0.4 |
| Net income for the period | 9.8 | 5.9 |
| Dividend | -4.6 | - |
| Annual share buyback | -1.2 | - |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 | -3.5 |
| Undated subordinated debt (including interest charges) | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | 0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |
Higher organic cash remittance and robust cash position at Holding
[c. 67; p. 23]
Cash remittance and position
- In EUR billion
Net Cash Remittance
[c. 68; p. 23]
Net Cash Remittance
| FY24 | FY25 | |
|---|---|---|
| Proceeds related to in-force treaties2 | 0.6 | |
| Ordinary cash remittance | 7.1 | 7.5 |
| Total | 7.7 | 7.5 |
| Remittance ratio1 | 82% | 82% |
[c. 69; p. 23]
Net Cash Remittance
| FY24 Cash position | 4.0 |
|---|---|
| Net cash remittance from subsidiaries | +7.5 |
| Dividend | -4.6 |
| Annual share buyback | -1.2 |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 |
| Holding costs and interest expenses | -1.3 |
| Change in net debt | +1.6 |
| M&A and other | +3.1 |
| FY25 Cash position | 5.6 |
Solvency II at 224%
[c. 70; p. 24]
- Foreseeable dividends: EUR -4.8bn
- Provision for annual share buyback for 2026: EUR -1.25bn
[c. 71; p. 24]
Eligible Own Funds (EOF)
| FY24 | Regulatory & model changes | Normalized capital generation | Operating variance | Economic variance & FX | Dividend & annual share buyback | Management actions, debt & other | FY25 |
|---|
[c. 72; p. 24]
Solvency II ratio movements
- Solvency II ratio: 55.9 (reported)
- Solvency II ratio movements: +0.2 from operating return; +8.8 from market impacts; -0.4 from capital management; -2.1 from regulatory changes; -6.0 from other impacts; -0.1 from FX
- Solvency II ratio at period end: 56.4 (reported)
[c. 73; p. 24]
Solvency II ratio
| FY24 | Regulatory & model changes | Normalized capital generation | Operating variance | Economic variance & FX | Dividend & annual share buyback | Management actions, debt & other | FY25 |
|---|
[c. 74; p. 24]
Solvency II ratio evolution
- Solvency II ratio was 216%.
- The ratio increased by +28pts due to operating return.
- The ratio decreased by -1pt due to market impacts.
- The ratio increased by +4pts due to capital management.
- The ratio decreased by -24pts due to regulatory changes.
- The ratio increased by +2pts due to other effects.
- The final Solvency II ratio was 224%.
[c. 75; p. 24]
Solvency Capital Requirement (SCR)
| FY24 | Regulatory & model changes | Normalized capital generation | Operating variance | Economic variance & FX | Dividend & annual share buyback | Management actions, debt & other | FY25 |
|---|
[c. 76; p. 24]
Solvency II ratio bridge
- Solvency II ratio bridge: 25.9 (start); 0.0 (operating capital generation); +0.6 (market impacts); 0.0 (non-operating items); -1.2 (
Key sensitivities
[c. 77; p. 24]
Impact by scenario
| Scenario | Impact |
|---|---|
| Ratio as of December 31, 2025 | 224% |
| Interest rate +50bps | +2 pts |
| Interest rate -50bps | -1 pt |
| Corporate spreads +50bps | -1 pt |
| Euro Sovereign spreads +50bps1 | -1 pt |
| Credit migration2 | +2 pts |
| Listed Equity (excl. PE & Infra) +25% | -7 pts |
| Listed Equity (excl. PE & Infra) -25% | -4 pts |
| PE & Infra +25% | +14 pts |
| PE & Infra -25% | -19 pts |
| Inflation swap curve +50bps | -5 pts |
Solvency II – impact of the end of grandfathering period and Solvency II revision
[c. 78; p. 25]
Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision
| Ratio as of 31/12/2025 | 224% | |
| Impact of the end of grandfathering period on January 1, 2026 | -10pts to 215% | Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
| Impact of Solvency II revision to come into effect in 1Q27 | +17pts1(footnote: Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.) |
No change expected in organic capital generation
Additional capital flexibility
Conclusion
[c. 79; p. 26]
Group CEO
- Thomas Buberl is the Group CEO.
Conclusion
[c. 80; p. 27]
Business performance and outlook
- Record results were achieved at the top end of the target range while enhancing reserve prudence.
- All businesses are in excellent shape, delivering strong growth and profitability.
- The diversified franchise is well-positioned to capture future growth opportunities.
- Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth.
Q&A
[c. 81; p. 28]
Date
- February 26, 2026
AXA Investor Relations – Keep in touch
Meet our management
[c. 82; p. 29]
Investor relations calendar
- March: Roadshows in Europe and US
- May 5: 1Q25 Activity Indicators in Paris
- June 2: BNP Paribas Exane CEO Conference in Paris
- June 2-4: Goldman Sachs European Financials Conference in Zurich
- July 31: HY26 Earnings Release in Paris
- September 21: AXA Investor Day in London
Contact us
[c. 83; p. 29]
Investor Relations contact
- Investor Relations contact: +33 1 40 75 48 42
- Investor Relations email: investor.relations@axa.com
Follow us
[c. 84; p. 29]
AXA website
- AXA website: www.axa.com
Appendices
[c. 85; p. 31]
Appendices overview
- The document includes appendices on: Debt and Invested Assets; Additional P&C disclosures; Additional IFRS17 disclosures.
Gross financial debt and maturity breakdown as of December 31st, 2025
[c. 86; p. 32]
Gross financial debt and maturity breakdown
- All figures are in EUR billion.
Gross financial debt
[c. 87; p. 32]
Debt gearing
- Debt gearing: 20.6% (prior: 22.3%)
[c. 88; p. 32]
Gross financial debt (In Euro billion)
| FY24 | FY25 | Jan 1st 2026 | |
|---|---|---|---|
| Total | 19.2 | 20.3 | 20.3 |
| Tier 1 | 4.8 | 4.6 | 3.2 |
| Tier 2 | 10.8 | 12.2 | 11.3 |
| Senior debt | 3.5 | 3.5 | 5.8 |
[c. 89; p. 32]
Gross financial debt details
- End of the grandfathering period
- EUR 0.4bn redeemed in Jan 2026
Contractual maturity breakdown
[c. 90; p. 32]
Contractual maturity breakdown (In Euro billion)
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Senior debt | 1.5 | 0.5 | |||||||
| Tier 2 | 0.5 | 0.9 | 0.7 | 10.8 | |||||
| Tier 1 | 4.6 |
[c. 91; p. 32]
Contractual maturity breakdown
- Grandfathered debt is included in the contractual maturity breakdown.
[c. 92; p. 32]
Tier 1 & Tier 2 by 2025, 2026, 2027, 2028, 2029, 2030, 2031-2039, ≥2040, Undated
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Tier 1 | - | - | - | - | - | - | - | - | 1.4 |
| Tier 2 | - | - | - | - | - | 0.7 | - | 0.2 | - |
Economic maturity breakdown
[c. 93; p. 32]
Economic maturity breakdown by senior debt, Tier 2, Tier 1
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Senior debt | 1.5 | 0.5 | |||||||
| Tier 2 | 0.1 | 2.4 | 0.1 | 0.5 | 2.0 | 6.4 | |||
| Tier 1 | 0.9 | 0.7 | 0.4 | 4.0 |
[c. 94; p. 32]
Grandfathered debt
- o/w Grandfathered debt
[c. 95; p. 32]
Tier 1 & Tier 2 by economic maturity
| 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated | |
|---|---|---|---|---|---|---|---|---|---|
| Tier 1 | - | 0.1 | - | 0.1 | - | - | 0.4 | - | 0.8 |
| Tier 2 | - | - | - | - | - | 0.7 | 0.2 | - | - |
General Account Invested Assets
[c. 96; p. 33]
General Account invested assets duration gap
- FY25 Total General Account invested assets Duration gap at -0.4 year
[c. 97; p. 33]
FY25 Total General Account invested assets: Euro 450 billion
| Fixed income |
| Real estate |
| Infrastructure equity |
| Listed equities |
| Private equity and hedge funds |
| Cash |
| Policy loans |
[c. 98; p. 33]
Invested assets (100%) In Euro billion
| FY25 | % | |
|---|---|---|
| Fixed income | 345 | 77% |
| o/w Government bonds | 167 | 37% |
| o/w Corporate bonds and loans | 121 | 27% |
| o/w Other fixed income 1 | 56 | 13% |
| Real estate | 41 | 9% |
| Infrastructure equity | 10 | 2% |
| Listed equities 2 | 10 | 2% |
| Private equity and hedge funds 3 | 23 | 5% |
| Cash | 19 | 4% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets 4 | 450 | 100% |
Structured and Private Credit assets
[c. 99; p. 34]
Invested assets (100%) by Total Structured and Private Credit Assets
| Invested assets (100%) In Euro billion |
FY25 | % of total G/A1 portfolio | Comments |
|---|
Residential Mortgages164%- €6bn Dutch mortgages, NHG guaranteed
- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
CLO & ABS256%- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
Infrastructure debt82%- Skewed towards resilient industries (Telecom, Utilities, Transport)
CRE debt82%- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
Mid-Market lending102%- Strong diversification with €8m average ticket
- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
Other20%
Total Structured and Private Credit Assets6915%o/w 54% participating
Investment portfolio – Fixed Income reinvestment
FY25 Fixed Income Reinvestment
[c. 100; p. 35]
Fixed income reinvestment portfolio
- Government bonds & related comprise 32% of the portfolio with an average rating of AA.
- Investment grade credit comprises 40% of the portfolio with an average rating of A.
- ABS/CLO/IG fund financing comprises 21% of the portfolio.
- Below investment grade credit comprises 7% of the portfolio.
- The total reinvestment amount is EUR 57bn.
FY25 Fixed Income Reinvestment Yield
[c. 101; p. 35]
Fixed income reinvestment yield by public, private & structured fixed income
| Public fixed income1 | Private & Structured fixed income2 | Total fixed income |
|---|---|---|
| 3.5% | 4.7% | 3.9% |
[c. 102; p. 35]
FY25 fixed income reinvestment yield
- EUR 57bn fixed income invested at 3.9%
- Average duration of 9 years
- Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
- Gradual shift from alternative total return assets to Private & Structured credit
[c. 103; p. 35]
FY25 Fixed Income Reinvestment Yield
[c. 104; p. 36]
Additional disclosures
- Additional P&C disclosures are on page 36.
- Additional IFRS17 disclosures are on page 41.
- Debt and Invested Assets disclosures are on page 31.
AXA XL Insurance – Large Commercial & Specialty business
Well diversified across lines of business and geographies
[c. 105; p. 37]
GWP by line of business
| Casualty | 35% |
| Property | 29% |
| Specialty | 19% |
| Professional lines1 | 17% |
[c. 106; p. 37]
GWP by geography
| Americas | 46% |
| Europe & APAC | 35% |
| UK & Lloyds | 19% |
Leading market positions across lines
[c. 107; p. 37]
Commercial lines market position
- Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie.
Managing the cycle to deliver consistent profitability
[c. 108; p. 37]
Profitability vs. Ex-price growth by line of business
- Profitability vs. Ex-price growth (%)
- Professional lines: lower ex-price growth, lower profitability
- Casualty: medium ex-price growth, medium profitability
- Specialty (including Cyber): medium-high ex-price growth, medium-high profitability
- Property: high ex-price growth, high profitability
P&C – Focus on Reserves
Claims reserves ratio
[c. 109; p. 38]
Claims reserves ratio definition
- Net undiscounted claims reserves / Net earned premiums.
[c. 110; p. 38]
| FY18 | FY19 | FY20 | FY21 | FY22 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|
| IFRS4 | IFRS17 | ||||||||
| Claims reserves ratio | 179% | 185% | 193% | 188% | 189% | 198% | 195% | 180% | 175% |
Technical reserves ratio
[c. 111; p. 38]
Technical reserves ratio definition
- The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.
[c. 112; p. 38]
| FY18 | FY19 | FY20 | FY21 | FY22 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|
| IFRS4 | IFRS17 | ||||||||
| Technical reserves ratio | 213% | 227% | 233% | 226% | 227% | 234% | 232% | 216% | 210% |
P&C – 2026 Simplified Group Nat Cat Reinsurance Program
[c. 113; p. 39]
Nat Cat Reinsurance Program
- All figures are in EUR.
Insurance segment (occurrence protection)
Reinsurance segment (illustrative)
[c. 114; p. 39]
Alternative Capital & Cat Bonds
- Alternative Capital & Cat Bonds
[c. 115; p. 39]
Capacity and Retention by peril
| EU Windstorm | Europe Flood | Europe Earthquake | NA Hurricane | NA Earthquake | Per other perils3 | |
|---|---|---|---|---|---|---|
| Capacity | 4.0bn | 2.1bn | 2.1bn | 1.2bn | 1.2bn | |
| Retention | 600m | 450m | 400m | 600m2 | 600m2 | 400m |
[c. 116; p. 39]
Retention levels
- Stable retention levels maintained in 2026 as in 2025.
[c. 117; p. 39]
Reinsurance segment (illustrative)
P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026
[c. 118; p. 40]
Nat Cat cost deviation
- Nat Cat cost deviation in 2026 is presented in EUR billion (net of reinsurance).
Group underlying earnings deviation to average Nat Cat charges in 2026
[c. 119; p. 40]
Nat Cat charges deviation
- The table presents Nat Cat charges deviation net of reinsurance, post-tax and pre-tax.
[c. 120; p. 40]
Deviation by percentile and return period
| Percentile | Return period | Deviation |
|---|---|---|
| 95th | 1/20y (more severe) | €-1.2bn |
| 90th | 1/10y | €-0.8bn |
| 80th | 1/5y | €-0.4bn |
| 50th | Median | €+0.1bn |
| 20th | 1/5y | €+0.5bn |
| 10th | 1/10y | €+0.7bn |
| 5th | 1/20y | €+0.8bn |
[c. 121; p. 40]
Nat Cat charges deviation
- Negative deviation in approximately 40% of cases for more severe years.
- Positive deviation in approximately 60% of cases for less severe years.
Average Expected Nat Cat charges
[c. 122; p. 40]
Value & Estimated impact on GEP by year
| 2025 | 2026 | |
|---|---|---|
| Value (€bn) | 2.6 | 2.7 |
| Estimated impact on GEP | ca. 4.5% | ca. 4.5% |
[c. 123; p. 41]
Additional disclosures
- Debt and Invested Assets are detailed on p.31
- Additional P&C disclosures are on p.36
- Additional IFRS17 disclosures are on p.41
P&C – Margin Analysis
Technical Result
[c. 124; p. 42]
Pre-tax technical result
- All figures are in EUR million (pre-tax).
[c. 125; p. 42]
Current Accident Year Undiscounted Technical Margin
| FY25 | Change | |
|---|---|---|
| Current Accident Year Undiscounted Technical Margin | 2,778 | +707 |
| Gross Earned Premiums | 57,656 | +6% |
| Current Accident Year Undiscounted Combined Ratio | 95.2% | -1.0pt |
| o/w Nat Cats | 3.4% | -0.4pt |
[c. 126; p. 42]
Current Accident Year Discounting by FY25
| FY25 | Change | |
|---|---|---|
| Current Accident Year Discounting | 2,009 | +115 |
| Discounting Ratio (in Combined Ratio points) | -3.5% | +0.0pt |
| Current Accident Year Net Claims reserves | €19.0bn | |
| Duration | 4.0 years | |
| Current Accident Year Discount rate | 2.8% |
[c. 127; p. 42]
Prior Years' Reserve Development (PYD)
| FY25 | Change | |
|---|---|---|
| Prior Years' Reserve Development (PYD) | 622 | -341 |
| PYD ratio | -1.1% | +0.7pt |
[c. 128; p. 42]
FY25 Current Accident Year discount rate sensitivity
- FY25 sensitivity to Current Accident Year discount rate changes: +25bps results in EUR +0.2bn; -25bps results in EUR -0.2bn.
Financial Result
[c. 129; p. 42]
Pre-tax results
- All figures are in EUR million (pre-tax).
[c. 130; p. 42]
Investment income
| FY25 | Change | |
|---|---|---|
| Investment Income | 3,988 | +435 |
| FY25 Average Assets | €115bn | |
| Asset book yield | 3.5% | |
| FY25 Reinvestment yield1 | 4.3% |
[c. 131; p. 42]
Insurance Finance Expenses
| FY25 | Change | |
|---|---|---|
| Insurance Finance Expenses | -1,358 | -235 |
| FY24 Reserves at locked-in rate | €71bn | |
| Liability book yield | 1.9% |
[c. 132; p. 42]
Insurance finance expenses
- 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn
- Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount:
- +25bps: ~ EUR -50m
- -25bps: ~ EUR +50m
[c. 133; p. 42]
Underlying Earnings before tax and Underlying Earnings
| FY25 | Change | |
|---|---|---|
| Underlying Earnings before tax | 8,040 | +681 |
| Tax | -2,060 | -169 |
| Affiliates, Minority interests & Other | -108 | -10 |
| Underlying Earnings | 5,872 | +501 |
| Growth vs. FY24 (at constant FX) | +9% |
L&H – Margin Analysis
[c. 134; p. 43]
Scope impact
- Scope impact is included.
Technical Result
[c. 135; p. 43]
Pre-tax technical result
- Pre-tax technical result in EUR million
[c. 136; p. 43]
Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio
| FY25 | Change | |
|---|---|---|
| Short-term Technical Margin | 479 | +60 |
| Gross Earned Premiums | 17,416 | +10% |
| All Year Combined Ratio | 97.2% | -0.1pts |
[c. 137; p. 43]
Long-term Technical Margin by CSM release and Technical experience
| FY25 | Change | |
|---|---|---|
| Long-term Technical Margin | 2,804 | +156 |
| CSM release | 2,954 | +215 |
| Technical experience | -150 | -58 |
[c. 138; p. 43]
Technical result adjustments
- The technical result includes the recapture of Laya.
[c. 139; p. 43]
FY25 CSM by sensitivities
(in Euro billion) FY25 Baseline33.3 Interest rates +50bps-0.8 Interest rates -50bps0.6 Sovereign spreads +50bps-1.9 Sovereign spreads -50bps1.9 Corporate spread +50bps-0.8 Corporate spread -50bps0.7 Equities +25%1.8 Equities -25%-2.2
Financial Result
[c. 140; p. 43]
Pre-tax result
- Pre-tax result (in EUR million, pre-tax)
[c. 141; p. 43]
Investment Income (non-VFA only)
| FY25 | Change | |
|---|---|---|
| Investment Income (non-VFA only) | 2,484 | -1 |
| FY25 Average Assets | €98bn | |
| Asset book yield | 2.5% | |
| FY25 Reinvestment yield1 | 3.8% |
[c. 142; p. 43]
Insurance Finance Expenses (non-VFA only)
| FY25 | Change | |
|---|---|---|
| Insurance Finance Expenses (non-VFA only) | -1,538 | -9 |
| FY24 Reserves at locked-in rate | €62bn | |
| Liability book yield | 2.5% |
[c. 143; p. 43]
Underlying earnings before tax and underlying earnings
| FY25 | Change | |
|---|---|---|
| Underlying Earnings before tax | 4,229 | +205 |
| Tax | -800 | 65 |
| Affiliates, Minority interests & Other | 72 | -51 |
| Underlying Earnings | 3,501 | +219 |
| Growth vs. FY24 (at constant FX) | +7% |
[c. 144; p. 44]
Additional disclosures
- Debt and Invested Assets disclosures are on p.31.
- Additional P&C disclosures are on p.36.
- Additional IFRS17 disclosures are on p.41.
Expanding AXA's role in society: AXA for Progress Index
[c. 145; p. 45]
Target and 2025 Result by Global Investor, Global Insurer, and Company
| As a GLOBAL INVESTOR | As a GLOBAL INSURER | As a COMPANY | |||
|---|---|---|---|---|---|
| Target | 2025 Result | Target | 2025 Result | Target | 2025 Result |
| €5bn2 in climate transition financing per year | €6.4bn | €6bn3 in P&C GWP to support transition underwriting (cumulative 2024-2026) | €4.6bn | >80,0006(footnote: Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.) AXA Group employees trained on climate adaptation by 2026 | 46,420 |
| >€500m2 in community resilience financing per year | >20,0004 climate adaptation solutions & services (cumulative 2024-2026) Target revised in 2025 | 19,698 Cumulative 2024-2025 | Contribute to Net-Zero -50%7(footnote: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.) by 2030 in absolute carbon emissions and offset of residual emissions8(footnote: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).) | -64% Reduction against 2019 | |
| €1.4bn | >20m5(footnote: Low-income to mass market segments in emerging markets and modest income segments in mature markets.) inclusive insurance customers by 2026 | 20.6m | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 | 56% | |
Sustainability Performance & Ratings
[c. 146; p. 46]
Sustainability ratings
- Dow Jones Best-in-Class Europe & World indices percentile: 97th in 2025
- MSCI score: AAA in 2025
- CDP score: B in 2025
- Sustainalytics ESG Risk Rating: 17.0 (Low risk) in 2025
- FTSE4Good Index Series score: 4.3/5 in 2025
[c. 147; p. 46]
Sustainability Performance & Ratings
Scope
[c. 148; p. 47]
Scope of activities by geography and segment
- France: includes insurance activities, banking activities, and holding.
- Europe: includes Switzerland (insurance activities); Germany (insurance activities and holding); Belgium and Luxembourg (insurance activities and holding); United Kingdom and Ireland (insurance activities and holding); Spain (insurance activities and holdings); Italy (insurance activities); Prima (insurance activities); and AXA Life Europe (insurance activities).
- AXA XL: includes insurance and reinsurance activities and holding.
- Asia, Africa & EME-LATAM:
- Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
- Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024, and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, underlying earnings, and net income.
- Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) are fully consolidated.
- EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
- EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
- EME-LATAM: AXA Mediterranean Holdings.
- Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
- AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method.
[c. 149; p. 47]
Accounting standards
- All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
- Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.
Glossary
[c. 150; p. 48]
Glossary of financial terms
- Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%
- Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders
- CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period
- Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force
- Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow
- Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business)
- Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities)
- New Business Value (NBV): the value of newly issued contracts during the current year
- It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests
- New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided
- New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP
- Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes
- Operating variance is net of reinsurance
- Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term
- PVEP is discounted at the reference interest rate and PVEP is Group share
- Technical experience: consists of the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses
- Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance
Thank you
[c. 151; p. 49]
Earnings presentation details
- Full Year 2025 Earnings presentation was on February 26, 2026.